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1. INTRODUCTION
Cholesterol and its relatives possessing the 1,2-cyclopenta-
noperhydrophenanthrene ring system (Figure 1) form the
sterolome, which comprises a chemical library of more than
1000 natural products found in all forms of eukaryotes and
some prokaryotes that serve a myriad of biological functions.
1,2
The structural and stereochemical commonality of these com-
pounds derive in large part from the action of oxidosqualene
synthases (formerly cyclases) that generate the parent sterol
frame.Intheir1985Nobellecture,BrownandGoldsteinstated
that“cholesterolisthemosthighlydecoratedsmallmoleculein
biology”, a comment supported by the many Nobel prizes
awardedto individuals who devoted a large partof their lives to
research one or more aspects of the chemistry and chemical
biology of sterols, their metabolites, or other isoprenoids.
2,3
Theﬁrstknownsterol,cholesterol,wasdiscoveredbyFrench
chemists as a crystalline component of human gallstones over
230yearsago.In1789,FrancoisPoulletierdeLaSalleobserved
an alcohol-soluble portion of bile stones, which 10 years later
was reported by De Fourcroy to be identical to a waxy material
in the fat of putreﬁed corpses referred to as adipocire.
4 Shortly
thereafter, Michel Chevreul established that the crystalline
component of bile stones, which gave a melting point of
137 C (accepted mp for cholesterol is 149 C), was distinct
from adipocire or that of another waxy material from whale,
spermaceti (their mp ranged 44 68 C), and named it “cho-
lesterine” from two Greek words: chole, meaning bile and
stereos, meaning solid.
4,5 In English-speaking countries, the
name cholesterin was replaced with cholesterol after recogni-
tion that the substance was as a secondary alcohol. The correct
formula (C27H45O , which here shows that it has a hydroxyl
group although it contains 46 hydrogen atoms) of cholesterol
was proposed in 1888 by F. Reinitze, yet it took another
30 years to establish the exact steric representation of the
molecule, eﬀorts that led to the Nobel Prizes in chemistry for
Wieland (1927) and Windaus (1928). The ﬁrst connection
between cholesterol and human health appeared in 1843 as
Vogel showed that cholesterol was present in arterial plaques.
5
Cholesterol was subsequently determined to be widely distrib-
uted in the animal kingdom and its isomeric forms, termed
“cholesterolbodies”orphytosterol,wereshowntofrequentthe
vegetable kingdom.
6 These early attempts at natural product
surveys of sterols were based on measurements of melting
point, color reaction, optical rotation, and crystalline form.
Sterol research changed in the mid- to late 20th century and
centeredonbiomimeticchemistry,tracerwork,enzymology,and
structure determination using high-ﬁeld NMR and X-ray diﬀrac-
tion methods, culminating with a broad outline for cholesterol
synthesis and the partial or complete puriﬁcation of all the
microsomal-bound enzymes that act on sterols between lanos-
terol and cholesterol.
7 13 Ergosterol, then cholesterol, was
discovered to play multiple cellular roles associated with mem-
brane(bulkrole)andsignal(sparking)functions,whichcouldbe
diﬀerentiated by structure and amount of compound;
14 17
notably sterols accumulate in cultured plant and animal cells at
approximately 3000 fg/cell and in yeast at 20 fg/cell.
18 During
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this time, there was a renewed focus on regulation of cholesterol
synthesis and human physiology.
19 These studies, which in-
volved oxysterols, led to the development of an inhibitor of
hydroxymethyl glutaryl CoA reductase (HMGR), atorvastatin
(Lipitor), which in 2006 was the best-selling drug in the world
grossingmorethan$12billiondollarsinsales.
20 22Furtherwork
on sterol biosynthesis demonstrated that lanosterol is the
product of squalene-oxide cyclizaton in organisms of a nonphoto-
synthetic lineage and cycloartenol is the product of squalene-
oxide cyclization in organisms of a photosynthetic lineage.
23 25
These ﬁndings show that sterol biosynthesis can proceed by
phyla-speciﬁc pathways.
Central to the advances of the past two decades is the
development of molecular genetic approaches that have wit-
nessed the cloning, primary amino acid sequences, and func-
tionalcharacterizationofalargenumberofenzymesthatacton
sterol and revealed unexpected inborn errors of cholesterol
metabolism. The full exploitation of these genes lies in medical
diagnostics, treatment, and the ability to ultimately engineer
phytosterol pathways to generate plants with tailored sterol
proﬁles for commercial production. Another spectacular dis-
covery involving
13C-isotopically labeled compounds supplied
to microorganisms and plants was the demonstration that the
classic acetate mevalonate pathway to animal cholesterol can
be replaced in the biosynthesis of algal sterols and other
isoprenoids by a mevalonate-independent pathway.
26,27 The
work on the biosynthesis of cholesterol and other sterols is
ongoing, and many talented investigators all over the world are
contributing to the latest surge of biochemical investigation.
Their eﬀorts constitute a collective undertaking of signiﬁcant
importance toseveral remarkable advances toward the comple-
tion of the enzymatic inventory of sterol synthesis, and these
new ﬁndings, together with a brief examination of prior art in
the ﬁeld of sterols, are discussed in this review.
2. STRUCTURE AND DISTRIBUTION
2.1. Sterol Frame and Functional Domains
Sterols are amphipathic compounds that originate in isopre-
noid biosynthesis with the main frame composed of a nucleus and
side chain (Figure 2). Accordingly, the sterol molecule possesses
four indispensible domains. In domain A, the polarity and tilt of
the C3 OH-group contribute functionally to hydrogen-bond
interactions. In domain B, the C4 and 14-methyl groups
can aﬀect the A ring conformation and back face planarity,
respectively. Alternatively, the number and position of double
bondsinthenucleuscanaﬀecttheshapeofthesterolandtiltof
t h e1 7 ( 2 0 ) - b o n d .I nd o m a i nC ,t h en a t u r a lc o n ﬁguration at
C20,R,determinestheconformationofthesidechaintoorient
into a “right-handed” side chain. In domain D, the conforma-
tion and length of the side chain, in addition to the stereo-
chemistry of the C24-alkyl group in phytosterols, are critical to
intermolecular contacts. These molecular features are crucial
for the Δ
5-sterol molecule to function in membranes as a ﬂat,
elongated compound of approximate volume 794 A
3;n o t a b l y ,
the cholesterol shape can be mimicked and its structure
replaced by sterol-like pentacylic compounds (hopanoids) in
bacteria having a smaller volume of 745 A
3.
28 Cholesterol has
eight stereocenters that give rise to 2
8 stereoisomers (256), yet
only one of them, the natural enantiomer with the 3R,2 0 R
conﬁgurations, is utilized as a membrane insert.
17 On the other
hand, the size and direction of the 24-alkyl group have
phylogenetic signiﬁcance; 24β-methyl sterols predominate in
less-advanced organisms, including many fungi and protozoa,
and 24R-ethyl sterols populate the sterol mixture of advanced
organisms, typiﬁed by vascular plants.
29 31
2.2. Nomenclature, Stereochemistry, and the Isoprene Rule
The earliest chemical deﬁnition for a sterol was provided
by Fieser and Fieser. These substances will possess the char-
acteristic perhydro-1,2-cyclopentanophenanthrene ring skele-
ton (Figure 1).
32 The revised 1989 nomenclature system
recommended by the International Union of Pure and Applied
Chemistry (IUPAC) and the International Union of Biochem-
istry (IUB) for the naming of sterols and related isoprenoids
permits unambiguous assignments of conﬁguration and intro-
duces a convenient and logical uniformity to the nomenclature
of all tetracyclic triterpenoids (Figure 3B).
33 However, the
recommendations can cause confusion with regard to the
phytosterol side chain structure and nomenclature, particularly
withrespecttotheapplicationoftheRandSdesignation,andin
NMR assignments. The revised system has further complica-
tionsandbecomescumbersomeasthecomplexityofside-chain
modiﬁcationsbybiosyntheticalkylationsincrease.
34,35Wehave
adopted the older convention (Figure 3A) and rely on the
biosynthetic side chain rule, which, for instance, states that the
E-methylgroup(C26)associatedwiththeΔ
24(25)-doublebond
in the sterol side chain can be shown to originate in C2-
mevalonic acid and the Z-methyl group (C27) to arise from
C6(C30)ofmevalonicacidwiththenumberingofthesemethyl
groupsretainedinthecaseofthecholesterolsidechain.
2,36This
subtle diﬀerentiation between the chemically equivalent but
biosynthetically distinct terminal methyl groups can be lost in
Figure 1. Common tetracyclic steroid frame containing the 1,2-cyclo-
pentanoperhydrophenanthrene ring skeleton.
Figure 2. Perspective drawings of the cholesterol molecule showing four domains of functional importance (left) and the ﬂat elongated structure
presumed to form in the membrane (right).6425 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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the numbering procedure adopted by the IUPAC IUB re-
commendations. Another convention relevant to this rule
involves chiral substituents at C24 to be designated R and β,
but this R/β notation is unrelated to the similar notation for
substiuents on the ring structure. The corresponding family of
phytosterols are then related to structures based in ergostane
(24β-methyl), campestane (24R-methyl), and stigmastane
(24R-ethyl)or poriferstane (24β-ethyl). The systematic names
ofthesterolsaretreatedasderivativesof5R-cholestan-3β-olor
that of a related stanol. As relevant, the corresponding trivial
name for a sterol may be used in place of the systematic name
for its familiaritywith thereader such as cholesterol rather than
cholest-5-en-3β-ol.
1,2,5,12
BecausesterolsarederivedfromtheC30squalene,theyareaclass
of triterpenoids. These tetracycles are generated from the linear
combinations of the C5-isoprenoid building block, isopentyl dipho-
sphate. In order to conform to the empirical isoprene rule,
triterpenes (C30)a r et h ep r o d u c t so fj o i n i n g6  5C 5-units.
37
Thousands of triterpene products have been reported from plants,
and they arise from more than 80 diﬀerent carbon skeletons; the
triterpene cyclase baruol synthase recently cloned can generate as
many as 23 products.
38 Sterols therefore form a unique family of
triterpenes that can be deﬁned on biosynthetic reasonableness. For
thisalternatedeﬁnition, thefocus is on the reaction mechanism and
ignores the precise isoprenoid character of the cyclization product,
assuming only that the intermediate adopts steroidal character
during cyclization to produce a tetracycle compound of speciﬁc
structure and stereochemistry. Thus, a true sterol is formed by the
electrophiliccyclizationreactionsthatpassthroughatransitionstate
similar to the trans syn trans anti trans anti conﬁguration
aﬀording a protosteroid C20 cation.
2 The cyclization product(s),
lanosterol or cycloartenol and in rare cases parkeol, should contain
absolute conﬁg u r a t i o n sa tC 3a n dC 2 0o ft h eR-orientation. In light
ofrecentworkfromCorey’slaboratory,theintermediateC20cation
is now known to assume the 17β-side chain (pseudoaxial side chain
generated by a 17R-hydrogen atom) required of the synthase to
establish the natural C20 conﬁguration of the sterol product.
39,40
The structure and stereochemistry for several structural isomers in
the tetracyclic triterpene series, including lanosterol, cycloartenol,
euphol, tirucallol, and cucurbitacin, have been established by X-ray
crystallography.
41 44Thelanostaneandcycloartanesterolskeletons
possess relative stereochemistry of 5R,8 β,1 0 β,1 3 β,1 4 R,1 7 R,a n d
20R conﬁgurations, consistent with their stereospeciﬁc formation
involving theprotosteroid cation, which agree with the stereochem-
istry in the cholestane frame resulting from their metabolism
(Figure 4).
2.3. Variation in Sterol Construction
Principal diﬀerences in cholesterol and related phytosterols
are in the side chain (C20 C26/C27), which has diﬀerent
degrees of substitution and unsaturation. Chemical surveys of
the sterol composition of prokaryotes, eukaryotes, and sedi-
mentary organic matter show that there are at least 250 sterols
and related steranes; in corn, 60 diﬀerent sterols have been
characterized.
45 47 Higher plants are a mixture of 24-alkylated
sterols, 24-ethyl and 24-methyl sterols generally accounting,
respectively, for more than 70% and less than 30% of the total
sterol. Djerassi and his associates, using a computer-assisted
program, calculate that natural sterols may have as many as
1778diﬀerentstructures;manyofthemmaybefoundinmarine
organisms, which are known to synthesize highly bioalkylated
sterol side chains.
48 The number of cholesterol variants can
increase by an order of magnitude by including cholesterol/24-
alkyl sterol derivatives to esters, glycosides, and sulfates and
those metabolites that retain the perhydro-1,2-cyclopentano-
phenanthrene skeleton. In animals, cholesterol is converted to
sex hormones, bile acids, vitamin D, and diﬀerent classes of
“oxysterols”, in insects to ecdysteroids, and in nematodes to
dauer steroids, whereas in plants, cholesterol is converted to
C27-spirostanols to form glycoalkaloids and saponins or C23
cardenolides.
1,2,49 Alternatively, the C28-a n dC 29-phytosterols
metabolize to the plant defense withanolides (from 24(28)-
methylene cholesterol),toplant growthhormone brassinoster-
oids (from campesterol),or to fungal sex hormones antheridiol
and oogoniol (from fucosterol) in the Oomycetes.
50 52
3.0. BIOGENETIC CONSIDERATIONS: HISTORICAL
PEDAGOGY
3.1. Ionic Reactions
Accordingtothecurrentlyacceptedhypothesis,theformation
ofsteroidsproceedsbyacationiccyclizationprocess.Thistheory
Figure3. Twosystemsrecognizedfornumberingofcarbonatomsofthesterolnucleusandsidechain.Theconventionalsystem,whichincorporatesthe
R/β-chiral descriptors in nucleus and side chain is based on the Fieser and Fieser book Steroids and biosynthetic considerations as discussed in refs 1, 2,
and 5 (panel A), versus the 1989 IUPAC recommendations (panel B).6426 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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has it roots in the biogenetic isoprene rule of Ruzicka and his
associatesinZurichwhoconsideredbiosynthesisoftriterpenoids
was initiated by an electrophilic attack on a double bond of a
linear polyprenoid substrate forming a cyclic (or polycyclic)
intermediate cation, which, in turn, can then undergo various
transformationsandrearrangements.
37Carbocationicintermedi-
ates can also arise in the presterol segment of isoprenoid
biosynthesis, and they include allylic pyrophosphates that gen-
erate allylic carbocations on elimination of pyrophosphate.
Ionization of the allylic pyrophosphate leads to formation of a
charge-stabilizedallyliccation.Thecationscanreactwithalkenes
to form new carbon carbon bonds using Δ
2-IPP (dimethyl allyl
pyrophosphate)asasourceofallyliccarbocations,suchthatafter
trans elimination of a proton, a new prenyl diphosphate is
generated that is ﬁve carbons larger (Figure 5).
5,53 For these
biochemically rare electrophilic additions to a double bond to
proceed, the divalent metal ion binds to the pyrophosphate
moiety of the allylic cosubstrate so as to make it a better leaving
groupintheionizationstep.Twostructurallyunrelatedclassesof
isopentyl diphosphate isomerase (IDI) are known. Type I IPP
(IDI-1)utilizesadivalentmetalinaprotonation deprotonation
reduction. In contrast, the type II enzyme (IDI-2) requires
reduced ﬂavin, raising the possibility that the reaction catalyzed
by IDI-2 involves the net addition or abstraction of a hydrogen
atom.
54 Other coupling reactions contribute to squalene bio-
synthesis, the most notable being that involved in the two-step
reaction yielding squalene from farnesyl diphosphate (FPP).
55,56
First, one molecule undergoes loss of PPi and addition of the
allylic carbocation to the alkene end of the other molecule of
FPP, accompanied by loss of a proton, to form presqualene
pyrophosphate. In the second step, presqualene pyrophosphate
(PSPP) loses PPi, and the presumptive cyclopropylcarbinyl
Figure 4. Thecyclization of squalene-2,3-oxide (i) foldedin either the chair chair chair boat unfolded(ii)orchair boat chair boat unfolded(ii)
conformationstoyieldacation(ii),whichcanstabilizetoproducethedammarane,tirucallane,euphane,andcucurbitaneskeletons(viapatha)orcycloartane
and lanostane skeletons (via path b). Generally, the cyclization products contain a 3β-OH group and a Δ
8-bond or in the case of cucurbitacin a Δ
5-bond.
Figure 5. The prenyl transferase reaction and formation of farnesyl diphosphate (FPP). Prenyl (C5) units composed of isopentyl diphosphates (IPP)
are assembled in a head to tail fusion to yield C10 (geranyl diphosphate, GPP) and in repeat fashion to C15 (FPP) isoprenoids. Alternate isoprene unit
assemblies yield a variety of diﬀerent structures notable in terpene metabolism. Enz = enzyme and M
++ can be Mn
2+ or Mg
2+ ions.6427 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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carbocation undergoes ring opening and reduction by NADPH
to squalene (Figure 6).
Rahierandco-workershavedrawnattentiontoionicprocesses
that generate sterol cations concomitant with allylic rearrange-
ments, double bond C-methylations, or reduction reactions in
the postsqualene segment of sitosterol biosynthesis (Table 1).
11
Themostcelebratedandbestcharacterizedoftheseelectrophilic
processing enzymes has been the sterol C24-methyltransferase
(24-SMT), attracting justly deserved attention, not only for its
centrality in phytosterol diversity but for possible inactivation by
catalyst-speciﬁc drugs in ergosterol biosynthesis to treat human
infections.Abroadunifyingmechanisticframeworkfortheorigin
of all phytosterol side chains that included the intermediacy of a
cationic intermediate at C25 in the conversion of Δ
24(5)-t o
Δ
24(28)-sterols was provided by Castle et al. in their demonstra-
tion of the incorporation of the S-methyl of methionine into
sitosterol in Pisum sativum.
57
3.2. Formation of Steroidal Backbone
The usual pathway to the C30 primary sterols proceeds along
the well-established isoprenoid trail that leads from the “active
isoprene unit”, isopentenyl diphosphate, to the C30 triterpenoid
squalene. The biosynthesis of C30 sterols from squalene and
thence to cholesterol can be outlined in three major stages as
envisioned by Bloch:
58 acetate f isoprenoid intermediate f
cyclization product f cholesterol. Stage 1 involves (i) conver-
sionof acetyl CoA into acetoacetyl CoA catalyzed by acetoacetyl
CoA thiolase (AACT), (ii) conversion of acetoacetyl CoA into
3-hydroxyl-3-methylglutaryl CoA by hydroxyl-3-methylglutaryl
CoA synthase (HMGS), (iii) conversion of 3-hydroxy-3-methyl-
glutaryl CoA into mevalonic acid (MVA) by 3-hydroxy-3-
methylglutaryl CoA reductase (HMGR), (iv) conversion of
MVA into phosphomevalonate by phosphomevalonate kinase
(MK), (v) conversion of phosphomevalonate into diphospho-
mevalonate by phosphomevalonate kinase (PMK), and (vi)
conversion of diphosphomevalonate into isopentyl diphosphate
(Δ
3-IPP) by mevalonate diphosphate decarboxylase (MVD).
Thus, in the ﬁrst stage MVA is transformed into IPP by two
phosphorylation steps at C5 of MVA and a decarboxylation/
elimination step; IPP, the basic C5 building block, is then added
toprenyldiphosphatecosubstratestoformlongerchains.Δ
3-IPP
itselfisinsuﬃcientlyreactivetoundergoionizationtoinitiatethe
Figure 6. Proposed mechanism for the coupling of farnesyl diphosphate (FPP) to form squalene.
Adapted with permission from ref 53. Copyright 2009 American Chemical Society.
Table 1. Electrophilic Reactions Catalyzed by Sterol Biosynthesis Enzymes6428 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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condensation of higher isoprenoids. Therefore, it is ﬁrst iso-
merized to the allylic ester Δ
2-IPP through an antarafacial
rearrangement followed by head to tail condensation of Δ
2-
andΔ
3-IPPtoformgeranyldiphosphatebygeranyldiphosphate
synthase (DPS). In the second stage, the condensation reaction
is repeated by the addition of Δ
3-IPP producing the C15 allylic
product farnesyl diphosphate. Two molecules of farnesyl dipho-
sphate condense tail to tail to the C30 acyclic polyene squalene
by the action of squalene synthase (SQS). The C30 symmetric
oleﬁn undergoes oxidation to form S-oxidosqualene via an
NADPH-dependent mono-oxygenase reaction catalyzed by
squalene epoxidase (SQE), and this substrate can be cyclized
by an oxidosqualene sterol synthase to yield the steroidal
backbone structure represented in lanosterol. In stage 3, lanos-
terol is converted to cholesterol (section 4.4).
In the early phase of cholesterol research, it was not immedi-
atelyapparentthattheC27structure ofcholesterolwasrelated to
lanosterol, since it failed to be divisible by C5 units. To establish
isoprenoid character, several groups incubated [1-
14C]acetate
and[2-
14C]acetate withliverslices aﬀordingadecisive patternin
the distribution of acetate carbon atoms in the labeled cholester-
ol. As shown in Figure 7, where “M” denotes an acetate methyl
and “C” an acetate carboxyl carbon, there are three places in the
molecule where a repeating C5 pattern typical of isoprene can be
recognized.Thesetracerstudiesalsoprovidedthefoundationfor
the acetate mevalonate pathway in sterol biosynthesis.
1,2,5 The
stereochemistry of the enzymatic reactions involved with bio-
synthetic steps that lead to squalene, lanosterol, and cholesterol
have been completely elucidated by the work of Popjak and
Cornforth using six species of MVA stereospeciﬁcally labeled
with either
2Ho r
3H at C2, C4, or C5.
5,59 Seo and co-workers
complemented this work by feeding [5-
13C
2H2]MVA together
with [2-
13C
2H3]acetate or [1,2-
13C2]acetate to yeast and cul-
tured plant cells.
60 Using
13C NMR spectroscopy, they con-
ﬁrmed the fate of all the relevant hydrogen atoms comprising
MVAincorporatedinto
13C-labeledergosterol,cycloartenol,and
sitosterol.
Since the late 1960s, it has been known that two major
cyclization pathways exist for the conversion of oxidosqualene
to steroidal tetracycles; lanosterol is formed in organisms of a
nonphotsynthetic lineage, and cycloartenol is formed in organ-
isms of a photosynthetic lineage by independent synthase
enzymes.
2,9 This biosynthetic bifurcation in sterol biosynthesis
is one of the most interesting phylogenetic markers available
because it has no apparent inﬂuence on the structure of the
functional steroid at the end of the pathway and the enzymes
themselves are membrane-bound though not in plastids (e.g.,
cycloartenol).
By carrying out experiments with doubly labeled
[2-
14C(4R)4-
3H1] MVAfedtoanimalandplanttissues,Goad
and Goodwin demonstrated that cycloartenol having a
3H/
14C
atomic ratio of 6:6 is not produced by rearrangement of
lanosterol having a
3H/
14C atomic ratio of 5:6, consistent with
retention of label at C19 in the biosynthetically formed
cycloartenol.
61 Altman and co-workers studied cycloartenol
biosynthesis in the alga Ochromonas malhamensis. Incubation
of oxidosqualene bearing a chiral methyl group (H,
2H,
3H) at
C6 with the plant synthase revealed that the stereochemistry of
the cyclopropane ring closure proceeds with retention of
conﬁguration.
62 These variant synthase-mediated substrate
transformations were formerly postulated to involve a con-
certed ring annulation that led to a C20 protosterol intermedi-
ateinwhichthecationicsidechainatC17isR-oriented(C17β-
hydrogen),aﬀordingtheunnaturalC20Sarrangement.Toform
the natural 20R conﬁguration, it was postulated that interven-
tion of an electron-donating “X-group” on the synthase takes
placetotransientlyneutralizetheC20charge.
63,64Utilizationof
the X
 -group permits rotation about the 17(20)-bond of 120
prior to hydride migration. A ﬁnal elimination reaction takes
place at C9R to produce lanosterol.
65,66 In contrast to forma-
tion of a “ﬂat” Δ
8(9)-sterol, formation of “bent” cycloartenol
requirestheproductbendthroughalmost90toaccommodate
the9β,19-cyclopropane-8β-Hbridgeheadinwhichthe19-CH3
and 8H-atom are cis to one another.
5,14,24,67,68 For “bent”
cycloartenol formation, a distinct enzyme substrate interac-
tionfromtheoneinvolvedatC20isconsideredtointerceptthe
positivechargegeneratedatC9R (Figure 8).
9,67Ring construc-
tion in this pathway requires a 1,3-anti elimination of a proton
from the C19 angular methyl group and theaddednucleophile.
If this is not done, the ﬁnal step, migration of a hydrogen from
C19-methyl, will be cis to the C9 hydrogen transfer instead of
trans in order to conform with the biogenetic isoprene rule.
Subsequent withdrawal of the X
  then permits closure of the
cyclopropane ring in a trans manner with concomitant removal
of the C19 proton, which is tantamount to a double inversion
mechanism. These postulates are revisited in section 4.
4. RECENT ADVANCES IN STEROL BIOSYNTHESIS
4.1. The Genome Sterol Metabolome Congruence
Thediﬀerentmolecularlibrariesthatconstituteisoprenoid 
sterol metabolomes across Kingdoms are organized through a
series of discrete assemblies of enzymatic reactions, which are
characterized compartmentally. The acetate MVA pathway to
squalene oxide is considered to be the main route to the
production of steroidal backbones. Recent international eﬀorts
have resulted in the complete sequencing of the model plant
Arabidopsis, nonpathogenic fungus Saccharomyces,a n dh u m a n
genomes.
69 71 In the entirely sequenced genomes of these
organisms, homologues for all genes of the acetate MVA
pathway to sterols are present. The functional genomics
approachtogetherwiththeestablishmentofdefectivebiosynth-
esis steps in humans and generation of yeast and plant mutants
insterolbiosynthesisenabledtheelucidationofstructuralgenes
Figure 7. Distribution of acetate carbon atoms found in cholesterol; a
repeating pattern of ﬁve carbon atoms (isoprene unit), surrounded by
dotted lines, is recognizable in three places in the molecule.
Adapted with permission from ref 5. Copyright 1986 Plenum Press,
New York.6429 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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for the individual enzymes in sitosterol, ergosterol, and choles-
terol formation.
72 74 Notably, sterol biosynthesis in plants and
fungidiﬀermarkedlyfromthatinanimalssincetheseorganisms
contain more sterol genes than do animals. In nonanimal
systems diﬀerent sterolic genes can encode for similar reaction
steps, for example, sterol C24-methyltransferase, sterol C14-
demethylase, or sterol methyl oxidase, whereas mammals gen-
erally have only a single gene for each enzymatic step. The best
Figure 8. Interpretation of the mechanism of squalene-2,3-oxide cyclization to lanosterol and cycloartenol according to refs 61, 63, and 64. The
cyclization mechanisms are hypothesized to require “X
  group” (any electron-donating group on the enzyme) participation to generate the C20R
conﬁguration, which requires the side chain of the X
  group bound protosteroid to rotate from left to right about C20 and formation of “bent”
cycloartenol from a “ﬂat” 9β,19-cyclosteroid intermediate. See text.
Adapted with permission from refs 61 and 64. Copyright 1977 American Chemical Society and 1968 Biochemical Journal.
Figure 9. Overview of compartmentalized isoprenoid sterol biosynthesis pathways. Feeding studies of [2-
13C]leucine or [1-
13C]glucose distinguish
the leucine HMGCoA, acetate mevalonic acid (MVA) or the 2-C-methyl-D-erythritol-4-phosphate (MEP) pathways that contribute carbon to
isopentenyl diphosphate (IPP). The
13C-labeling pattern of ergosterol (synthesized in all major eukaryote Kingdoms) reveals which of the pathways
operate in a given organism and whether cross-talk between the pathways exist. In the forward direction, IPP converts to ergosterol or IPP can
retroconvert via the MVA shunt to HMGCoA and to acetate. See text.6430 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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described gene gene product pairing is in the yeast pathway
for which every relevant gene in the conversion of lanosterol to
ergosterol has been identiﬁed. The principal enzymes of
lanosterol conversion to cholesterol are coded for by nine
genes (section 4.4). The fungal 24-alkyl sterol pathway has
acquiredatleastfouradditionalgenesfromthehumanpathway
that give rise to a sterol C24-methyltransferase, sterol C22-
desaturase,sterolC24 24(28)-reductaseandsterolΔ
24(28)-to
Δ
24(25)-isomerase as reported in the ascomycetes, Saccharo-
myces,a n dGibberella.
18 Plants, variably from algae to tracheo-
phytes, have evolved all 11 of the fungal/animal sterol genes
andcancodefortwomoreofthem,thesterolΔ
25(27)-reductase
and 9,19-cyclopropyl to Δ
8-isomerase. To date, the number of
sterolgenesinvolvedinconversionoflanosterolorcycloartenol
to Δ
5-sterol is 15. Isoforms can exist to alter the number of
enzymatic reactions in a speciﬁc pathway.
4.2. Biosynthesis of Squalene: MVA versus MVA-Indepen-
dent Pathways
At least two alternative biosynthetic pathways to Δ
2-(dimethyl
allyl pyrophosphate) and Δ
3-isopentenyl diphosphate (formerly
pyrophosphate) have been shown, by biosynthetic labeling
studies, that can supply prenyl units to squalene, which in turn
is converted to sterols (Figure 9). One involves acetate directly
Figure10. Thecyclizationofsqualene-2,3-oxide(1)catalyzedbythelanosterolsynthase(LAS)orcycloartenolsynthase(CAS)togivetruesterols.
Ring annulation proceeds by synthase (cyclase)-speciﬁc cationic mechanisms involving a common protosteroid cation (17R-H/17β-side chain
orientation, 3). The cyclization cascade terminates with formation of either (i) intermediate 4 (LAS) followed by its deprotonation at C9 or C7 to
form lanosterol 11 or lanosta-7,24-dienol 12, respectively or (ii) intermediate 6 (CAS), which depending on the position of deprotonation at C7,
C19, or C11 yields lanosta-7,24-dienol 13, cycloartenol 14,o rp a r k e o l15,r e s p e c t i v e l y ;trans-cyclization of the chair boat type of system in 6a
(natural intermediate compared with 6b as discussed in the text) aﬀords the 9β-H instead of a 9R-H, which is necessary to complete biosynthesis of
cholesterol.Theasymmetricconformationofboundintermediates4and6witha20R-H-atom(20R-conﬁguration)eclipsedto17R-H-atomproduce
anenzyme-bound“left-handed”rotameratC20.Afterreleaseoftruesterols7 10fromtheactivesite,thesterolsidechaincanrotateaboutC20,such
that C21 and C22 lies in a 1,3-diaxial relationship with C18 to form the energetically favorable “right-handed” conformation of 11 to 15 utilized in
membranes.6431 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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incorporated into the MVA pathway after activation into acetyl
CoA. The other, known as the methyl-D-erythritol 4-phosphate
(MEP) pathway or mevalonate-independent pathway, utilizes
triose phosphate units as the precursor and is located in the
plastid of plants.
75 77 The former pathway uses seven enzymes,
some of which have crucial isoforms that contribute to drug
sensitivities, compared with the latter pathway that consists
of eight reactions catalyzed by nine enzymes. Many of these
enzymes have been characterized structurally. In the newly
discovered mevalonate-independent pathway reported indepen-
dently by Rohmer who detected it in eubacteria and Arigoni
who detected it in higher plants,
75,76 Δ
2-IPP (dimethyl allyl
diphosphate) is formed directly from pyruvate rather than via
acetyl CoA MVA and Δ
3-IPP. Terpenoids of the C10,C 15,C 20,
andC40skeletonsaregenerallysynthesizedwithintheplastidand
sterols synthesized in the cytosol of higher plants. Goad and co-
workers reported that mitochondria of some parasitic protozoa
have the capability to convert leucine to MVA, which then
converts to IPP and ergosterol via the cytosol.
78 Alternatively,
isopentenyl diphosphate can undergo catabolism through an
“MVA shunt” pathway (also known as the Popjak shunt”) that
forms a non-sterol-forming pathway to redirect ﬂux to small
molecules or fatty acids in animal, fungal, or plant tissues.
79 81
The MVA shunt, a multidirectional pathway, can allow carbon
from amino acids to be incorporated into IPP; isovaleric acid
has in its metabolism intermediates common to those in the
shunt pathway.
It has been possible to establish the contribution of these
variantisoprenoidpathwaystosterolbiosynthesisinplantsand
microorganisms by the retrobiosynthetic approach. When, for
example, [1-
13C]glucose, [2-
13C]acetate, L-[2-
13C]leucine,
[2-
13C]MVA, or [2,3,4,5-
13C4]1-deoxy-D-xylulose is used, the
MVA and MEP pathways yield distinctive labeling patterns in
IPP and sterols. Thus, in higher plants, sitosterol can be made
by either the MVA or MEP routes; the MVA pathway is always
senior to the MEP pathway. In the diatom Rhizosolenia setigera
that can synthesize 24-ethyl sterol, the MEP pathway is
favored.
27 In the photosynthetic alga Scenedesmus obliquous
and nonphotosynthetic yeast-like Prototheca wickerhamii
(cycloartenol route) that synthesize 24-methyl sterols, the
MEP pathway operates to the exclusion of the acetate MVA
as shown by the distinctive
13C-labeling pattern of ergosterol,
which possesses 10 rather 15 of its carbons enriched with
13C
after incubation with [1-
13C]glucose (Figure 9).
82,83
4.3. Cyclization of Squalene Oxide to Lanosterol or
Cycloartenol
By far the best studied of the enzymes involved in sterol
biosynthesis are the lanosterol and cycloartenol synthases. For
cyclization, the reaction requires (3S)-2,3-oxidosqualene ﬁrst to
adopt a preorganized chair boat chair conformation. Proton-
ation of the epoxide ring then triggers a cascade of stereospeciﬁc
ring-forming reactions to protosterol 3 channeled to speciﬁc
outcomesforthediﬀerentsynthases(Figure10).Recentﬁndings
oftheCoreygroup,studyinglanosterolformation,demonstrated
that the initial substrate cation in the chair boat chair boat
ring conformer 3 generates a 17β-side chain (17R-hydrogen)
that connects to the sterol side chain at C20; the resulting cis
C17H and C20H geometry orients the side chain into a “left-
handed” structure.
83 The protosterol cation converts to lanos-
terol 11 by elimination of the 9R-H atom (originally the 9βHo f
the protosteroid cation), which requires nuclear rearrangements
that involve a series of 1,2-shifts of hydride and methyl groups in
an antiparallel manner coupled to quenching of the positive
charge at C20. The C9β-hydrogen on the protosteroid cation is
then lost to the medium as a proton when the 8R-methyl
migratestoC14toformintermediate5,whichundergoesproton
abstraction at C9R to form the 8,9-double bond in 7.
66 Lanos-
terol cyclization may be considered complete when sterol 7
assumes the physiological conformation of the energetically
favored “right-handed” side chain (C17R-H and C20R-H trans
to one another in the usual view of the molecule) after product
release (Figure 9).
43
The postulated mechanism of cyclization of squalene oxide
into cycloartenol (and parkeol) is essentially the same as that for
lanosterol, except for the ﬁnal 9β,19 cyclopropane ring closure
with the 9β-H atom migrating to C8 instead of C9R proton
elimination. Nes found that the solid state and solution studies
unambiguouslyshowthatcycloartenolis“ﬂat”ofA/B/C-ringsin
the chair/half-chair/twist-chair conformer (Figure 11).
44a An
alternative reaction sequence to generate cycloartenol from
intermediate 3 (C9β) is to proceed to 6b (C8β) of constrained
boat structure (chair boat chair) and to 14, rather than to 6a
of chair chair chair conformation, which has resemblance to 4
to 12 (Figure 10); noticeably, the C9-cations in 6a and 6b
considered in the ﬁnal cyclopropane formation are on opposite
sides of the reaction intermediate.
Cloningandmutagenesisstudiesofcycloartenolandlanoster-
ol squalene oxide (= oxidosqualene) synthases [OSS] suggest
that the native enzymes in plants and fungi are catalytically and
Figure 11. Structure of “ﬂat” cycloartenol established by NMR (left) and X-ray (right) measurements.
Reprinted with permission from ref 44a. Copyright 1998 American Chemical Society.6432 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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structurally similar to the human oxidosqualene lanosterol and
bacterial squalene hopene cyclases.
65,84 86 The cloned and
puriﬁed human oxidosqualene cyclase is active as a monomer,
whereas the corresponding puriﬁed enzyme from bovine liver
exhibited active forms of 70 and 140 kDa, suggesting dimer
organization.
87,88 Insight into lanosterol scaﬀold formation from
the recently determined structure of human oxidosqualene
synthase reveals the presence of a cavity, shaped so as to accept
the substrate prefolded product-like conformation.
86 Structural
analysis, mutagenesis, and inhibition experiments have shown
that the protruding part of the protein contains a lipophilic
channel leading to the active-site cavity that can inﬂuence
substrate recognition (squalene versus oxidosqualene) and ac-
cesstotheactivesite.
89Directedmutagenesisofcycloartenoland
lanosterol synthases have shown that point mutations in the
active site can alter the cyclase product speciﬁcity. Mutations of
aliphatic residues in the cycloartenol synthase of Arabidopsis
thaliana and Dictyostelium discoideum resulted in a partitioning
shift from cycloartenol formation in the wild-type to lanosterol,
parkeol, and 9β-lanosta-7,24-dienol.
68 In a study on cycloartenol
synthase redesign, Matsuda and co-workers achieved the nearly
complete shift from cycloartenol to lanosterol (99%) formation
through engineering a double mutant of His
477Asn and
Ile
481Val.
90 These results show that only small changes in the
active site topography of these enzymes are required to fashion a
fungal/animal synthase from a plant synthase. Lanosterol, par-
keol,andlanostanederivativeswiththe9βH-sterochemistryhave
recently been found to occur naturally in plants,
12,91 raising
questions of their biosynthetic origin, that is, from preformed
cycloartenol. Detailed investigations of the steric and electro-
staticeﬀectsofconservedaromaticresiduesthroughsite-directed
mutagenesis experiments have revealed cation π interactions
that may inﬂuence the product outcome. Examination of yeast
ERG7 homology structure and human OSC structure suggest
that Tyr
707 and Tyr
99 residues in the Saccharomyces cerevisiae
ScERG7mightplay animportantroleinstabilizingtheC8cation
during the formation of the second cyclohexyl ring and the ﬁnal
lanosterol C9 cation.
65 On the other hand, Thomas and collea-
gues suggest the relevant active site amino acid in the human
synthase occurs at His
232, which is a strictly conserved residue
amongtheoxidosqualenecyclases,
89whereasChristiansonnoted
that Tyr
503 could possibly accept this proton because it is closer
and better-oriented with regard to the C9 proton that is
ultimately eliminated to form lanosterol.
92
Although cycloartenol is the ﬁrst cyclized product in plants,
lanosterol has been considered as an intermediate in phytosterol
biosynthesis. Several reports involving plant sterol biosynthesis
show similar rates of [2-
3H] (or
14C)-lanosterol and [2-
3H] (or
14C)-cycloartenol incorporation into phytosterols suggesting
that cycloartenol might transform to lanosterol via a 9β,19-
cyclopropanetoΔ
8-isomerasecatalyzedreactionasapreliminary
steptophytosterolformation.
93 95Thisreactionwouldallowfor
the cyclosterol intermediate (cycloartenol or some other cy-
closterol) to rearrange into the more stable structure that can
yield products having the C9R-H in Δ
5-sterols. However,
primary sequences of lanosterol synthase were discovered re-
cently in three diﬀerent laboratories from dicotyledonous plant
species, including Arabidopsis thaliana, Panax ginseng, and Lotus
japonica, using a yeast expression system that suggest that
lanosterol can be synthesized directly and independently from
cycloartenol.
96 98 Conservative patterns suggest that the Ile481
residue is partly responsible for the catalytic diﬀerences between
the lanosterol and cycloartenol synthases.
68 These ﬁndings
together with reports showing that radiolabeled squalene oxide
convertstolanosterolinacell-freelatexpreparationofEuphorbia
lathyris and intact Arabidopsis thaliana converts [6
13C
2H2]MVA
tolanosterol andphytosterolwithretentionofthree
2H-atomsat
C19 in the labeled products show the cycloartenol lanosterol
bifurcation in sterol biosynthesis is not absolute.
99,100 Moreover,
the cycloartenol and lanosterol synthases have been cloned and
functionally expressed from the same bacterium Stigmatella
aurantiaca, and the lanosterol synthase has been cloned from
other primitive organisms, including Methylococcus capsulatus
and Gemmata obscruiglobus.
101 104
4.4.TheCorePathway:LanosterolConversiontoCholesterol
Threediﬀerentapproacheshavebeenusedtostudythenature
and sequence of steps involved with sterol biosynthesis: organic,
enzymatic, and genetic approaches. The enzymatic approach to
understand and control formation of the sterol structure was
hampered by the low abundance of sterol enzymes in cell-free
preparations, as well as diﬃculties associated with purifying
microsomal proteins to homogeneity. By the early 1980s, it
was evident primarily from the pioneering eﬀorts of Gaylor and
hisco-workersatcatalogingthepropertiesofenzymesthatacton
sterols that an accurate sequence of 10 enzymatic reactions
performed by nine distinct enzymes can be written for the
lanosterol conversion to cholesterol as outlined in Table 2.
10a
These enzymes were shown to be integral membrane-bound
proteins of the endoplasmic reticulum.
Cholesterol synthesis requires one molecule of C30-4,4,14-
trimethyl sterol converted to C27-4,4,14-trisdesmethyl sterol
followed by the formation of a saturated isooctyl side chain
and Δ
5-bond in the ﬁnal product. The stoichiometry of choles-
terol synthesis from lanosterol is therefore lanosterol +
15NADPH + 4H
+ + 10O2 f cholesterol + 2CO2 + HCOOH +
15NADP
+. This process can be divided into two stages: stage 1
(reactions 1 6) represents the nuclear demethylation reactions
that fashion the lanosterol frame into the cholesterol structure.
Theproductofreaction6lacksmethylgroupsatC4andC14and
contains a 3β-OH group that is distinct from the one generated
by the cyclization of squalene-2,3-oxide to lanosterol. During
these conversions of the C4-sterol to a C4-desmethyl sterol, a
stable 3-keto sterol intermediate is formed. For stage 1, the
process consumes 12 NADPH, 2 NAD
+,9O 2, and 1 H
+.
Reactions 3 and 4 are enzymically coupled and repeated with
theresultingC4methylproductcatalyzedinreactions5and6;in
both sets of reactions two distinct enzymes, sterol C4-methyl
oxidase (4-SMO) and sterol C4-decarboxylase (4-SDC, also
referred to as 3β-hydroxysteroid dehydrogenase/C4-dec-
arboxylase), are utilized to carry out the overall conversion of
the sterol C4-demethylation reaction. Key to this series of
reactionsisthattheequatorial(intheplaneofthesterolnucleus)
methyl group of the 4,4-dimethyl and 4-monomethyl substrates
is recognized for catalysis. To maintain stereochemical consis-
tency in 4,4-dimethyl substrate recognition by 4-SDC, during
decarboxylation the methyl group that occupies the 4β-(axial)
position of the C4-dimethyl sterol epimerizes to the more stable
4R-(equatorial) position in the 4-methyl 3-ketosteroid product
and, in doing so, re-establishes the C4R conﬁguration. Thus, the
naturaloccurrenceofC4β-methylsterolsseemsunlikely.Stage2
(reactions 7 10) involves the rearrangement of the Δ
8-bond to
the Δ
5-position and saturation of the side chain double bond.
Reactionsinstage2consume3H
+,3NADPH,and1O2,andthe6433 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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enzymes act sequentially to convert the ring structure from a Δ
8
to Δ
7 to Δ
5,7 to Δ
5. Two enzymatic studies completed on the
cloned human sterol C8 C7 isomerase and microsomal rat
C24(25)-reductase after Gaylor postulated a lanosterol choles-
terol pathway clariﬁed the later sequence of reactions to
cholesterol.
105,106 These enzymatic studies reveal that the
Δ
24(25)-double bond of zymosterol is reduced prior to
Δ
5-desaturation.
The nine catalysts that convert lanosterol to cholesterol may
be considered the core enzymes of Δ
5-sterol biosynthesis. As
more enzymes have been isolated from an increasing number of
sources, it has become clear that they fall into only a small
Table 2. Biosynthesis Steps Involved in the Conversion of Lanosterol to Cholesterol
a
aSteps 3 to 4 and 5 to 6 involve two discrete enzymatic reactions, 4-SMO and 4-SDC; see text.6434 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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numberofreactiontypesandthatthechemicalnamesgivevaried
indication of this. In an attempt to rationalize this situation,
Table2includestrivialnamesoftheparentcatalystsandarelated
system of abbreviations proposed by the author. Although
cholesterol biosynthesis is often linked to the formation and
metabolism of C5 (isoprenoid = isopentenoid = terpenoid)-
units, the “sterol biosynthesis pathway”can bedeﬁned asthatset
ofenzymesthatactonthesterolstructure.Themostdirectroute
to cholesterol will be dependent upon the relative speciﬁcities of
theenzymesforaparticularsterolsubstratetherebygivingriseto
the kinetically favored pathway. When multiple routes are
postulated, it has been possible to draw a sterol biosynthesis
matrix for an organism, which can predict the main or trace
sterols which might be present, particularly after exposure to a
sterol biosynthesis inhibitor or genetic defect.
In the case of cholesterol biosynthesis from lanosterol, two
intersecting routes have been postulated. The choice of pathway
isdeterminedbythestageatwhichthedoublebondatC24inthe
sterol side chain is reduced. If C24 double bond reduction is
retained until the last reaction, cholesterol synthesis proceeds
via cholesta-5,24-dienol (desmosterol) (Bloch pathway). On
the other hand, early Δ
24-reduction involving lanosterol can
proceed to cholesta-5,7-dienol (7-dehydrocholesterol) and
cholesterol (Kandutsch Russell pathway). A common in-
terpretation regarding which pathway is utilized involves the
positioning of the Δ
24-reductase in cholesterol biosynthesis
such that skin and intestines, which have higher sterol
C24-reductase activities than liver or brain, proceed via
the C24 C25-terminal intermediates.
10b d Regardless of
tissue speciﬁcity, the kinetically favored pathway for choles-
terolbiosynthesisappearstoinvolvetheKandutsch Russell
pathway.
The relevant committed step that distinguishes sterol from
isoprenoid triterpenoidbiosynthesisoccursatthecyclizationof
oxidosqualene. Major control points in sterol biosynthesis may
arise in the primary pathway before squalene formation at
Figure 12. A generalized route from cycloartenol 1 to Δ
5-24R/β-ethyl sterols, stigmasterol 18 and poriferasterol 23, respectively.6435 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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hydroxymethyl-glutaryl-CoA reductase (HMGR) (coarse
control)
3 or after squalene formation at the sterol C24-methyl-
transferase(24-SMT)step(ﬁnecontrol)
107speciﬁctoorganisms
other than animals. Cofactor control by diﬀerential allocation of
oxygen, NADPH, and AdoMet can further inﬂuence reaction
rates and product distributions in cholesterol or phytosterol
biosynthesis.
4.5. C24-Alkylation Reduction Bifurcation in Phytosterol
Synthesis
Early attempts to deduce sterol biosynthetic pathways in
systems other than animals were based largely on indirect
approaches that included structural and stereochemical correla-
tionsofco-occurringmetabolitesandinvivotracerstudies.Using
microsome preparations of corn, Rahier, Benveniste, and their
co-workers systematically worked through the major enzymatic
reactions from cycloartenol to sitosterol and established sub-
strate preference for many of these enzymes.
11 The accumulated
evidence supports the kinetically favored pathway to Δ
5-sterol
synthesis from cycloartenol illustrated in Figure 12.
2,11,72 Cho-
lesterol can accumulate in plants by reduction of the Δ
24-bond
dependingontheexpressionofthesterolC24-methyltransferase
enzyme, as demonstrated in genetically modiﬁed Arabidopsis
plants.
108 The 24-SMT is recognized ﬁrst in the phytosterol
reaction sequence in plants and in some fungi. The typical
products of transmethylation of the substrate Δ
24-bond are the
C24-methyl Δ
24(28)- and Δ
25(27)-oleﬁns, or in rare cases they
become the 24-methyl Δ
23(24) (corn)- or Δ
24(25) (protozoa)-
oleﬁns(Figure13).
109 111Terrestrialorganisms,aswellasmany
pathogenic fungi and protozoan parasites synthesize 24-alkyl
sterols, whereas animals, especially humans, lack the 24-SMT
gene. Biomimetic studies of electrophilic alkylations of a remote
double bond support the detection of multiple outcomes of
enzyme-generated 24-alkyl sterol oleﬁns
112 Separate biosyn-
thetic routes, which have the following diﬀerences—major
sterols are 24R-ethyl sterols or 24β-ethyl sterols or cholesterol
and cyclopropyl or 24-methyl(ene) sterols replace 24-ethyl
sterols as the major compounds in the sterol mixture, can be
generally categorized and result in the production of diverse
sterol compositions.
Inorganismsthatliveinthemarineworld,sterolmethylation
patterns vary greatly and reﬂect the complexity of mixtures of
sterols arising through the food chain. The 24-SMT of these
organismscatalyzebranchedandhighlyalkylatedsidechainsof
distinctstereo-andregiochemistry,includingtris-orquadruple
alkylation of the C11 side chain, not typically observed in the
sterolmethyltransferasecatalyzedproductsofterrestrialorgan-
isms that produce C8 and C9 side chains (Figure 13). Whereas
plants can synthesize as many as 60 sterols, marine organisms
have been shown to contain as many as 74 sterols in a single
organism.
113 Dinoﬂagellate algae that form the ocean ecosys-
tem are diﬀerent from other algae and plants in their ability to
synthesize 22,23-cyclopropyl sterols, eﬀectively from an ergos-
terol-containing side chain. Biosynthesis of many other non-
conventionalphytosterols arepostulatedtoresultfrom nucleo-
philes for these reactions that originate in Δ
22-, Δ
23-, Δ
24-,
and Δ
25-oleﬁn-containing side chains. The stereochemistry
of the transmethylation reactions and subsequent side chain
modiﬁcations by reduction have been subjected to detailed
investigation.
114 The translational signiﬁcance for unearthing
unconventional sterols, such as the 24-isopropyl steranes, in
fossil remains is that their chemical ﬁngerprint provides relevant
biomarkerinformationaboutsterolevolutionanditsrelationship
to speciation.
115,116
5. STEROL ENZYME ACTION
5.1. C24 Methylation
In reviewing the action of enzymes that catalyze sterol
formation, it has been found convenient to divide topics accord-
ing to the properties of the enzyme that include its speciﬁcity,
mechanism, inhibition, and where evidence is available results of
mutagenesis experiments. We start with the enzymatic C24-
methylation reaction, where progress has been made in identify-
ing the genes and catalytic properties of the corresponding
proteins. Four diﬀerent sterol C24-methyltransferase enzymes
Figure 13. The sterol alkylation reaction pathways operating in diﬀerent organisms; routes 1 in fungi, protozoa, and plants to form C9 and C10 side
chains and routes 2 and 3 to form C11 extended side chains in marine organisms.6436 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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(24-SMT) have been detected and classiﬁed according to the
substrate favored by the enzyme for catalysis. Plants synthesize
two 24-SMTs, SMT1, which prefers cycloartenol ((EC 2.1.1.142),
and SMT2, which prefers 24(28)-methylene lophenol (EC
2.1.1.143); some fungi and protozoa synthesize 24-SMT1 of
substrate preference for zymosterol (EC 2.1.1.410), and other
fungi also synthesize 24-SMT with a substrate preference for
lanosterol.
111,117 120 In all cases studied, the catalysts shared
similar properties of subunit organization as homotetramers of
Mr 38000 43000, as determined by SDS-PAGE and gel
permeation, and each contained a single active site for sterol
and AdoMet. An interesting feature of several of the cloned 24-
SMTs is their ability to produce multiple and distinct product
sets at either the C1-o rC 2-stage of methylation.
111,120,121
So far as is known, 24-SMTs vary in sequence identity
(49 77%), the whole family containing only about 63 com-
pletely conserved residues (less than 20% of an average of
ERG6). Twenty ﬁve of these residues lie in the substrate
binding segments, and another 38 lie outside of these areas.
122
T h ec l o n e de n z y m e ss h a r es i m i l a rs l o wt u r n o v e rn u m b e r so f
kcat=0.01s
 1andpHoptimaof7.5.Steady-statekineticstudies
show fungal SMT1 (S. cerevisiae) AdoMet and zymosterol bind
randomly to the enzyme. Alternatively, the plant SMT1
(G. max) exhibits an ordered binding mechanism, AdoMet
binds ﬁrst, followed by the methyl acceptor cycloartenol.
118,123
The structure of 24-SMT has not been established. In the
absenceofatomiccoordinates,thegeneralcharacteristicsofthe
24-SMTactivesitehavebeenprobedbymeansofphotoaﬃnity
labeling using AdoMet, suicide substrates using 26,27-dehy-
drozymosterol and site-directed mutagenesis experiments.
These studies, focused on the S. cerevisiae 24-SMT, have
identiﬁed several conserved amino acids that cluster in sets of
approximately11residuesinfoursubstratebindingsegmentsof
the protein; homology modeling shows that region II contains
the Rossmann fold, which consists of central β-sheets ﬂanked
by R-helices, and the experimental data shows contact amino
acids that can interact with AdoMet and regions I, III, and IV.
Thesterolbindingsegmentsweredeﬁnedthroughmutagenesis
experiments to give rise to gain-in-function activities that upon
m u t a t i o nc a nl e a dt ot h es e c o n dC 1-tranfer reaction character-
istic of plant 24-SMTs.
121,124,125
The 24β-chirality in algal ergosterol and the 24R-chirality of
vascular plant campesterol and sitosterol is considered to arise
from direct C24-alkylation or through a Δ
24(28)-sterol inter-
mediate, respectively. To account for the product diversity,
ionic and X
  group C24-alkylation mechanisms have been
proposed as shown in Figure 14.
125 127 The diﬀerent stereo-
chemical outcomes observed in ergosterol and sitosterol were
proposed to involve a C24-methylation reaction that led to a
C24S-methyl group (fungi) or C24R-methyl/ethyl group
(plant). In either case, C24-methylation was thought to gen-
erate the C25R-H chirality, which is analogous structurally to
thestereochemistryatC25inanimalcholesterol.Asenvisioned
in the mechanism for squalene oxide cyclization to sterols, the
C24-alkylationmechanismshouldincludeanucleophiliccenter
on the 24-SMT (X
 , unidentiﬁed amino acid) to form a
covalent bond with the C25 or C24 carbocation resulting from
the destruction of the Δ
24(25)-o rΔ
24(28)-bonds. The covalent
species are shown in mechanism b, and the formation of such
intermediates would obviate the necessity to form discrete
carbocations. The X
  group mechanism considered in 24-alkyl
sterol biosynthesis is based entirely on stereochemical consid-
erations that relate to changes in the conformation of covalent-
bound sterol-24-SMT of diﬀerent organisms directing the
chirality in enzyme-generated products.
In the ionic mechanisms, illustrated in paths a and c (see
Figure 14) the biomethylation reaction involves discrete carbo-
cationic intermediates that can be the result of synchronous
changes in bonding that occur in a concerted fashion to form a
single product or involve a stepwise process where topology is
maintained between the initiation and termination steps aﬀord-
ing multiple products. Ammonium and sulfonium analogs of the
hypothetical 24-methyl sterol C25/C24 cation intermediates
have been found to inhibit the C24-methylation, consistent with
a cationic reaction mechanism in sterol alkylations.
128 Equilibri-
um binding of the transition state analog 25-azalanosterol
(charged at physiological pH) to yeast 24-SMT indicated that
its Kd wassimilartothat of the sterol acceptor andAdoMet, ca.4
μM, whereas the Ki for 25-azalanosterol against zymosterol
(Kmapp =3 5μM), determined by steady-state kinetic analysis,
is ca. 20 nM. These results suggest that the 24-SMT undergoes a
conformational change upon inhibitor binding for the substrate
analog to interrupt catalysis.
130,131
Arigoni and colleagues reported the preparation of
[
1H
2H
3H]AdoMet (only one enantiomer of the chiral methyl
group was present) and have used it to probe the stereochemical
course of a methyl transfer to carbon in fungal production of
ergosterol. The results obtained indicate that the chirality of the
acetate derived from the methyl group at C24 in ergosterol was
the same as that of the methyl group of methionine but with a
reduction inchiral purity.
132Thisaddition eliminationreaction
proceeds with inversion at the transferring, chiral methyl center
yieldinganSN2mechanismforthemethyltransfer.Thequestion
astowhichsideofthedoublebondoftheΔ
24-sterolacceptorthe
Figure 14. Mechanisms for methyl transfer to Δ
24(25)-substrate in the
actionofsterolC24-methyltransferase;dotshowsto
13C-labeledcarbon.
In mechanisms A and C, the carbocationic intermediates are discrete
species, and an important diﬀerence between the two mechanisms
involves the SN2( Si, β)-attack of methyl cation on the substrate double
bond coupled to the regiospeciﬁc deprotonation at C28 to yield the 25S
stereochemistry typical of 24-alkyl sterols of the ergostane and stigmas-
tanefamily.InmechanismB,theformationofcarbocationintermediates
isavoidedbypostulatingtheparticipationofanenzymaticnucelophile-X
to form covalent bonds with incipient cations to yield the C25R
stereochemistry typical of animal cholesterol.
Adapted with kind permission of Springer Science and Business Media
from ref 67, Copyright 1977 Springer-Verlag, and from ref 123, Copy-
right2003TheAmericanSocietyofBiochemistryandMolecularBiology.6437 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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incoming methyl group is added was resolved by studying the
metabolic fate of the pro-Z methyl of various Δ
24-
13C27-sterols
incorporated into ergosterol and comparing the isotopically
labeled natural product, found to have the 25S-conﬁguation, to
chemically synthesized 25-S-[
13C]ergosterol.
133,134 The results
showthattheﬁrstC1-transferreactionmediatedbytheplantand
fungal 24-SMTs proceeds by alkylation from the Si-face of the
substrate Δ
24(25) (yielding β-methyl stereochemistry) followed
by migration of a hydrogen from C24 to C25 across the Re-face.
Yagi et al. investigated the second C1-transfer reaction
by feeding a set of [26-
13C], [27-
13C], and [26,27-
13C2]-
desmosterols (cholesta-5,24-dienol) to cultures of Ajuga reptans
andfoundthattheC24-alkylationtakesplaceinaspeciﬁcmanner
wherein the C26- and C27-methyl groups of the substrate
become C26 (vinyl methyl) and C27 (exomethylene carbon),
respectively of the 24β-ethyl Δ
25(27)-sterols synthesized by the
plant.
135Regiospeciﬁcity directedat Δ
25(27)-oleﬁnformation was
conﬁrmed using microsomal preparations of Prototheca wickerha-
miibythedemonstrationthat
13C-labelatC27(pro-Zmethyl)in
the lanosterol substrate is retained in the enzyme-generated 24β-
methyl Δ
25(27)-product.
136 Using cloned Arabidopsis 24-SMT1,
we subsequently demonstrated that conversion of [27-
13C]-
fecosterol (C1) to [27-
13C]24(28)Z-ethylidenefecosterol (C2)
takes place with retention of conﬁguration at C25.
135 Studies of
synthesized [28E-
2H]- and[28Z-
2H]-24-methylene sterol accep-
tors transmethylated to give 24-ethyl(idene) sterol products
established that the second methylation proceeded in such a
manner that addition of the methyl group and proton loss occur
on opposite faces of the original Δ
24(28)-double bond.
123,137 On
thebasisoftheseobservationsandrecognizingthat24-SMTscan
be bifunctional and capable of operatong successive transfer
reactions to yield multiple products, we proposed the C24-
methylation reaction illustrated in Figure 15, in which the C28
elimination occurring on the isofucosterol cation during the
second C1-transfer reaction occurs by an anti-mechanism.
123
Kinetic studies involving
2H-substrates have revealed
another important feature of the reaction catalyzed by the
soybean 24-SMT enzyme. Thus, incubation of AdoMet versus
[methyl-
2H3]AdoMet as substrate against saturating concentra-
tions of cycloartenol aﬀorded a kinetic isotope eﬀect of VCH3/
VCD3 close to unity.
123 Similarly, incubation of [24-
2H]cyclo-
artenolfailedtoproduceanyapparentisotopeseﬀectsrelatedto
the1,2-hydrideshiftofH24toC25,consistentwithaconcerted
mechanism intheﬁrstC1-transferreaction. However, substrate
bindingexperimentsof[28E-
2H]-and[28Z-
2H]-24-methylene
sterol acceptors to determine isotope eﬀects associated with
formation of multiple product resulting from the second C1-
transfer reaction demonstrated that [28E-
2H]-oleﬁna ﬀorded a
KIE ((kH/kD) observed) of 0.92 for the deprotonation step
whereas for the [28Z-
2H]-oleﬁn a KIE of 1.23 was obtained.
The inverse value established by the isotoptically sensitive
branching experiments for the second C1-transfer reaction is
strong evidence that the proton transfer from the substrate to
the active site base has to come to equilibrium prior to the rate-
determining transition state and supports the proposal of a
discrete carbocation intermediate.
We reasoned further that it would be possible to diﬀerentiate
between the X-group and ionization mechanisms by selectively
substituting hydrogen with ﬂuorine or other atoms in the vinylic
substrate. By changing the nucleophilicityof the sterol Δ
24-bond
by substitution of methyl or ﬂuorine for hydrogen signiﬁcantly
decreases the rate at which soybean 24-SMT catalysis proceeds
without aﬀect on the binding properties of the substrate appre-
ciably. The observedorder of Vmax/Km values, H(34) < CH3(6)
Figure15. C1-TransfermechanismsintheconversionofΔ
24(28)-substrateinto24-ethyl(idene)products.Ineachcase,theisotopicallylabeledsubstrate
contains a
13C-27 atom (dot) and a Z-o rE-
2H-atom selectively introduced at C28. The “cis-process” has been eliminated by experiment.
Adapted from ref 123. Copyright 2003 The American Society of Biochemistry and Molecular Biology.6438 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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<F(0.9),clearlycorrelateswiththecarbocationstabilizingability
of the C25 group, where catalysis of the 24-methyl and 24-ﬂuoro
derivatives aﬀorded putative 25-hydroxysterols (Table 3).
The 24-bromo derivative 12 was not an acceptable substrate
although it could serve as a competitive inhibitor (Ki approxi-
mately 32 μM) of the C24-methylation reaction of soybean
24-SMTs.
138 141
The trapping of intermediary carbocations as diol structures
obtained by saponﬁcation of the sterol enzyme complex has
been accomplished by incubation of 17a and recovering of 17b
(Table 3).
124,131,141 The diol 17b was shown to be bound in an
ester linkage to the E68 residue of the yeast 24-SMT. The
trapping of a sterol methyl cation 17b is the ﬁrst example of an
intermediate of the 24-alkylation reaction from any source. The
structure and stereochemistry of the 24β-hydroxyl group was
proven by extensive NMR analysis and the addition of the C28
methyl group to C26 (rather than to C24) conﬁrmed by the
incorporation of three deuterium atoms derivedfrom incubation
with [methyl-
2H3]AdoMet. Also notable is the formation of a
diene structure in 17a in which double bonds are produced at
C23 and C25 in the sterol side chain, suggesting that cryptic
nucleophiles are present in the active site of these enzymes and
which readily explains the operation of the Δ
23(24)-route by the
corn 24-SMT. Aﬃnity labeling experiments using [3-
3H]26,27-
dehydrozymosterol or the methylenecylopropane derivatives
paired with [methyl-
3H3]AdoMet, which forms the ﬁrst potent
mechanism-based irreversible inactivator of the 24-SMT, de-
monstrated that the fungal and plant 24-SMTs were speciﬁcally
labeled and gave single bands on ﬂuorogram with apparent
molecular masses that matched the predicted molecular masses
Table 3. Sterol Analogs Tested with Sterol C-24-Methyltransferase Enzymes
a
aAn / on the compound number indicates putative. ND = not detected. Compounds 5, 7, 8, and 11 have been shown to be mechanism-based
inactivators. See text.6439 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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of the primary structures of the corresponding enzyme. Sub-
strates bearing a conjugated double bonds system in the side chain
at Δ
22,24 or Δ
24,26 are catalyzed by 24-SMT to product pairs,
which after saponiﬁcation of the enzyme preparation yield the
predicted C24(28)-sterol product and an uncommon C24-
methylated sterol with a hydroxyl group at C22 21 or C26 18b
(Table 3).
142 These analogs, like those formed by 24-SMT
catalysis of 26,27-deydrozymosterol, may also serve as suicide
substrates of the enzyme. The ability of 24-SMT to catalyze the
26-homosterol-Δ
22,24(26)-9 and 26,27-dehydro 7 analog show
thatlengtheningofthesidechainbyonecarbonatomisaccepted
by 24-SMT.
117,118,131,142
Because aromatic amino acid residues are crucial for the
oxidosqualene cyclization reaction catalyzed by lanosterol and
cycloartenol synthases, their possible role in related electro-
philic alkylation reactions catalyzed by 24-SMTs has been
studied. It is expected that the stereochemical course of the
C24-methylationreactionswouldbesubjecttothermodynamic
control, which is a measure of the energy needed to overcome
the activation barrier of sterol alkylation, and kinetic control,
which is a measure of the site-speciﬁc proton eliminations (e.g,
at C27 or C28) that govern product diversity.
131 Based on the
information from homologous alignment of the primary struc-
turesof24-SMTsthatshowthatregionIisveryrichinaromatic
amino acids, the highly conservedTyr
81 (ERG6 nomenclature)
inthefungalErg6pwasreplacedbyphenyalanineortryptophan
and mutated to a series of aliphatic residues of diﬀerent size
(glycine, alanine, leucine, and isoleucine).
124,125,130,131 The
substrates zymosterol and 26,27-dehydrozymosterol (1 and 7
i nT a b l e3 )w e r et e s t e da g a i n s tt h en a t i v ea n dm u t a n ty e a s t
24-SMTs. In the enzyme substrate complex, these chemically
distinct substrates catalyze to C24- or C26-methylated sterols.
When Tyr
81 in Erg6p is substituted with phenylalanine, the
enzyme becomes plant-like in its ability to recognize Δ
24(28)-
sterols and convert the exocyclic methylene side chain of
fecosterol to the same set of 24-ethyl(idene) products 15a,
15b,a n d15c (Table 3) that the soybean 24-SMT normally can
produce. Multiple products can also arise from incubation of
26,27-dehydrozymosterol with the wild-type Erg6p; the pro-
ducts are shown in Table 3 as 17a, 17b,a n d17c.M u t a t i o n so f
Erg6  at Tyr
81 involving the replacement to aromatics or
aliphatics had noticeable aﬀects on the partitioning outcome
of 26,27-dehydrozymosterol; mutating to aromatically favored
C26 monol 17a formation whereas mutating to favored alipha-
tic of smaller size C26 diol 17b and 17c formation (eﬀecting
enzyme alkylation and inactivation). In no case was zymosterol
converted to an intermediate that included a 25-hydroxy sterol
(i.e., a diol). Tyr
81 replacement of related aromatic amino acids
to 24-SMT and testing either substrate increased the rate from
0.04 min
 1 to as much as 0.20 min
 1, and substitution of
aliphatic residues led to decreased rates from 0.04 min
 1 to as
little as 0.007 min
 1. In the thermodynamic analysis, there was
no evidence for a change in the product ratio as a function of
temperature. This eﬀect is strongly suggestive of thermody-
namic control of the C24-methylation reaction. The energetic
costs associated with the enzyme substrate complex in the
transition state was found to be +13.7 kcal for zymosterol and
+15.6 kcal for 26,27-dehydrozymosterol. the activation diﬀer-
ences (Ea) relative to wild-type of +0.9 to  1 . 0k c a lf o rt h e
aromatics, in contrast to a diﬀerence in the Ea of +2.3 kcal for
the aliphatics. The diﬀerence in energy between the two
substrates in catalysis by the wild-type enzyme is +1.9 kcal
indicating that a higher energy route is required to reach the
transition state for 26,27-dehydrozymosterol catalysis consis-
tent with the topography of these interactions. It would appear
that the relative positioning of Tyr
81or its variants with respect
to the diﬀerent intermediates of zymosterol and 26,27-dehy-
drozymosterol catalysis in the activated complex of a tight or
loosely ﬁt structure almost certainly underlies the direction of
partitioning of the 24-SMT catalyzed reaction.
5.2. C24-Reduction
Sterol side chain C24-reductases (SR) are a family of NADPH-
dependent catalysts that transfer a hydride ion (H:
 ) to oleﬁnic
centersatC24orC25ofthesterolsidechain.Genescorrespond-
ing to the Δ
24(25)-reductase (24-SR) in humans (DHCR24 =
seladin-1), Δ
24(28)-reductase in fungi (28-SR, ERG24), and
Δ
24(25)-reductase in plants (DIM/DWF1) have been identiﬁed
andmodeledtoanalyzeitsbindingpropertiesbutinnocasehas
thecorrespondingenzymebeenclonedandpuriﬁedtoevaluate
theenzyme’sproperties.
143 145Interestingly,inthepathogenic
bacterium Coxiella burnetii that lacks de novo sterol biosynthesis,
the organism encodes a eukaryote-like Δ
24-sterol reductase
homologuethatisabsentinotherprokaryotes.
146Thepredicted
molecular weight of the human sterol 24-SR is 60.1 kD and
fungal 28-SR is 56.1 kDa. The enzymes themselves require no
cofactors other than NADPH. The conversion of fungal
Δ
24(28)-methylene sterol to 24β-methyl sterol has been
f o u n dt op r o c e e di nS. cerevisiae under strict anaerobic culture
conditions,
147 suggesting that sterol C24-reductases are
not oxygen-dependent and that these enzymes cannot be
operationally a ﬂavin dinucleotide (FAD)-dependent oxidor-
eductase-type enzymes as reported for the human sterol
C24-reductase.
145
The substrate speciﬁcity of the sterol C24-reductase has been
examined in two cases, in rat and insect (Manduca sexta)
microsomal preparations.
105,148 The catalytic competence for
the two enzymes diﬀer markedly in their recognition of the
cholestane and lanostane frame. The apparent Vmax/Km for
lanosterol and desmosterol are for rat 0.361 nmol/(min3mg)
and 109 μM and3nmol/(min3mg)and 163 μMcomparedwith
the insect 3 pmol/(min3mg) and 18 μM and 1 pmol/(min3mg)
and 3 μM, respectively. For rat, cholesta-7,24-dienol is the
optimal substrate for the enzyme yielding kinetic constants of
2 nmol/(min3mg) and 37 μM. Complicating the isolation and
study of these proteins from natural sources is the fact that many
Figure 16. Revised mechanism for the reduction of the sterol Δ
24-double
bondbytheactionofsterolC24-reductase(24-SR),whichusesNADPH
as coenzyme. The new hydrogen atoms (as hydrogen or tritium)
introduced are marked with circles, and
13C-labeled carbon is shown
with a dot. The mechanism requires introduction of a proton from an
activesitedonor,forexample,lysine,tothere-faceofthesubstratedouble
bond at C24 (1) followed by trans-addition of the hydride ion to
eliminate the carbonium ion at the si-face of C25 (2) thereby forming
the C26 Pro-R stereochemistry typical of animal cholesterol (3).6440 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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appeartobepresentinlowabundanceinthehostorganisms,and
for cloned enzymes, the membrane-bound nature of them can
interferewiththepuriﬁcationprocess.Bioinformaticanalysisand
homologymodelingofhumanDHC24RindicatesanN-terminal
segment (Leu
23-Trp
55), which may act as a membrane spanning
domain and a set of apolar residues at Ile
363, Leu
366, His
382,
Val
384, Trp
411, Ile
437, Ala
439, and Pro
443,a ﬀording hydrophobic
contacts with the substrate, whereas Ser
291 and Ser
295 provide
contacts to hydrogen bond with the sterol C3-hydroxyl
group.
145bThermodynamicanalysesthattakeintoconsideration
docking scores suggest that the human sterol C24-reductase
binds more stably to desmosterol,  30.18 kcal/mol, compared
with lanosterol,  12.87 kcal/mol, consistent with the substrate
preferences noted in the structure activity kinetic studies.
145b
Concerning the mechanism of the reduction, it was reported
tooccurbytheadditionofahydrogenfromthemediumatC24
and another from NADPH at C25.
149 Support for the cationic
nature of the enzymic reaction intermediate has been obtained
through observation that mimics of these species are eﬀective
inhibitors of the rat 24(25)-reductase and 24(28)-reductase of
yeast.
150,151 The stereochemistry of the reduction of the
24(25)-double bond in lanosterol or desmosterol synthesis
was originally studied by Caspi and his colleagues.
59 They
deduced that in the reduction of the 24(25)-double bond, both
hydrogens are added to the re-face of the double bond,
equivalent to a cis addition of the hydride ion to C25 from
NADPH and a proton (from water) to C24. As Popjak and co-
workers observed, in the
13CN M Ro f[
13C10]cholesterol
derivedfrom[30,4-
13C2]mevalonate,C26andC27oflanosterol
(or of desmosterol)become, respectively, the pro-R (C26) and
the pro-S (C27) of methyl groups in the side chain of
cholesterol, aﬀording the 25R-stereochemistry for the reduc-
tion of the 24(25)-double bond.
152 T a k a h a s h ie ta l . ,3 0y e a r s
later, reexamined the stereochemistry of the C24,25-double
bondintheconversionofdesmosteroltocholesterolinratliver,
silkworm, and plant (Oryza sativa) preparations by incubation
of [24-
13C,24-
2H]desmosterol.
153 In contrast to the original
ﬁndings where the hydrogen atom from the medium should be
β-oriented, the Japanese group determined, by using deuter-
ium-decoupled
1H,
13C shift correlation NMR analysis of the
biosynthesized cholesterol, that the stereospeciﬁc incorpora-
tion of hydrogen atoms occurs from the re-face of the C24-
position of the Δ
24(25)-substrate generating an R-oriented
hydrogen. It was also found using intact Manduca sexta, that
conversion of [24-
2H]lanosterol to [24-
2H]dihydrolanosterol
proceeds with retention of
2H at C24 and that incubation of
[4-pro-S-
3H]NADPH paired with desmosterol leads to the
incorporation of tritium into cholesterol.
148 The summation
of the stereochemical experiments are illustrated in the revised
mechanism of sterol C24-reduction illustrated in Figure 16,
which shows that the addition of hydrogen on the substrate
24(25)-double bond takes place in anti fashion from the re-face
of C24 and the si-face of C25 and that the pro-S hydrogen is
transferred from a nicotamide cofactor to the C25 cation
intermediate. The only other enzymatic studies of sterol side
chainreductasebeyondthoseinvolvingΔ
24(25)-reductaseshave
targeted the yeast sterol 28-SR, which has been found to prefer
ergosta-5,7,22,24(28)-tetraenol as the optimal substrate and to
require NADPH in conversion of the 24(28)-double bond to
24β-methyl sterol.
154
Figure 17. Phyla-speciﬁc pathways for the regio- and stereospeciﬁc reduction of a remote double bond in 24-alkyl sterol side chains. Three distinct
sterol reductases are considered in the formation of the C24-methyl/ethyl and C25-H stereochemistry, sterol C28-reductase (28-SR), sterol C25-
reductase(25-SR),andsterolC24-reductase(24-SR).Products8,9,and10canoriginatebytheactionofthesameplant24-SR.Dotindicates
13C27-
labeled atom. See text.6441 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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Theformationof24β-or24R-alkylsterols canbetheresultof
stepwise involvement of three enzymes, the sterol C24-methyl-
transferase (24-SMT), the sterol C24(28)- to C24(25)-isomer-
ase (24-ISO), and one or another C24(25)- or C25(27)-sterol
reductase enzymes (C24-SR or C25-SR).
155 160 The mechan-
ism for the double bond isomerization from Δ
24(28)-t oΔ
24(25)-
sterol was established by feeding [28-
13C,28-
2H]isofucosterol to
cellculturesofOryzasativaandanalysisofsitosterolformedfrom
24-ethyldesmosterol; the double bond isomerization takes place
in a syn-SE-20 manner wherein the pro-S hydrogen at C28 of
sitosterol is introduced from the 28-si face of isofucosterol. A
similar isomerization mechanism was demonstrated in the
biosynthesis of campesterol and 24-epicampesterol from
24(28)-methylene cholesterol.
161
As evident in the labeling of the sterol side chain C26
(or C27) with
13C, the two common sterol alkylation routes
involving the Δ
24(28) and Δ
25(27)-pathways (Figure 17) are
now known to proceed to 24β-methyl sterols of opposite C25
stereochemistry(compare7 and 8 in Figure17).
155Moreover,
the C25 stereochemistry of fungal and algal ergosterol and
plant campesterol and sitosterol are 25S, which is opposite to
the C25R stereochemistry of cholesterol synthesized in plants
oranimals.
132,152,156 160Thestereochemistryofthereduction
of 24-methyl/ethyl Δ
24(25)-sterol intermediates to form 24R-
and24β-methyl/ethylsterolshasbeeninvestigated.Toexplain
theformationofthetwoepimersatC24forC24-methylsterols
and the formation a single 24R-ethyl sterol, one proposal
suggests the reaction to consist of an addition of a H
+ on the
re-face of the Δ
24(25)leading to a three-center carbocation and
then an attack of H
  from NADPH would then occur either at
C24 or C25 leading to the formation of 24-methyl sterols of
opposite stereochemistry. To explain the diﬀerences of regios-
peciﬁcity, Bladocha and Benveniste suggested that steric
hindrance caused by the bulky ethyl group at C24 would favor
H
 additiontoC25,whereasnosuchconstraintswouldexistin
the case of C24-methyl sterols, allowing attack of H
  at both
C24 and C25.
163 A more probable mechanism has been
elucidated by Fujimoto by feeding [26-
13C]- and [27-
13C]-
labeled 24-methyldesmosterol to cultured plant cells. The
stereochemistry of reduction of 5 to 7 and 8 (Figure 17)could
arise by either a syn or anti mechanism, as was discussed in the
reduction of the Δ
24(25)-bond in cholesterol synthesis.
159,160
Theresultsrevealed thatstereospeciﬁchydrogenattack on24-
si,25-re face of 24-methyldesmosterol aﬀords campesterol,
whereas 24-epicampesterol is produced by 24-re,25-si attack
of hydrogen on the same Δ
24(25)-oleﬁn. The reductions that
leadtothe24-methylgroupofoppositestereochemistryevolve
f r o mt h es a m ee n z y m ea n dp r o c e e di na nanti-mode of
hydrogen addition in both cases. The 24R-ethyl stereochem-
istry likely is formed by the same anti mechanism. The
stereochemistry of algal ergosterol synthesized by the
Δ
25(27)-pathway is reported to be 25S analogous to fungal
ergosterol, which obtains the C25 stereochemistry by the 1,2-
hydrideshiftofH24toC25duringtheC24-alkylationreaction.
In algal ergosterol, the reduction performed by a 25-SR likely
proceeds by an anti mechanism as well. Still unclear is the
abilityoftheΔ
24(25)-reductasetodiscriminatesubstratesof24-
H,24-methyl,and24-ethylrankingreﬂectedmechanisticallyin
the enzyme’s ability to catalyze epimeric mixtures utilizing
24-methyl- but neither 24-desakyl or 24-ethyl Δ
24(25)-sterol
substrates.
5.3. Removal of Nuclear Methyl Groups at C4
The geminal methyls at C4 initially associated with lanosterol
and cycloartenol are eliminated in two separate processes: an
O2-andNADPH-dependentformationofa4R-carboxysterolmeta-
bolite followed by an O2-independent but NAD(P)
+-dependent
oxidative decarboxylation of this intermediate. In contradistinc-
tion to C32 removal, which occurs as formic acid, C4 methyl
removal occurs as CO2. The loss of the 3R-hydrogen atom
during C4 demethylation is universal, consistent with the inter-
mediacy of a β-keto acid at C3. Notably, during decarboxylation
the methyl group that occupies the 4β (axial) position of 1
epimerizes to the more stable 4R (equatorial) position as shown
7and, indoing so, re-establishesthechiralityat C4asR-oriented
(Figure 18).
Figure 18. Stereochemical scheme for the stepwise enzymatic removal of C4R-methyl group and reduction of C3 ketone to produce a 3β-hydroxyl
group.Theﬁrstsetofenzymaticreactions(1 5)iscatalyzedbyC4-sterolmethyloxidase(4-SMO)incomplexwithO2,NADPH,andCytb5yieldinga
C4-oxygenated intermediate. The second set of reaction steps (5 7) involves C4-sterol decarboxylase (4-SDC) [3β-hydroxysteroid dehydrogenase/
C4-decarboxylase (4-HSD/D)] and NAD
+ catalyzing sterol 3-ketone formation; 4-SMO and 4-SDC are coupled but separate reactions. The third
enzymatic reaction (7 8) involves sterol 3-reductase (3-SR) in complex with NADPH yielding 3β-hydroxy sterol. In the conversion of a 4,4-dimethyl
sterol (e.g., lanosterol) to a C4-mono methyl sterol (e.g., 31-norlanosterol), the C4β-methyl group in the substrate 1 epimerizes to become the C4R-
methyl group 8 in the product as shown. See text.6442 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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Recent study of cloned enzymes showed that the overall C4
demethylation process involves (i) the sequential reaction of
C4R monohydroxylation of the 4,4-dimethyl substrate and
oxidation of the CH2OH group to the carboxyl stage catalyzed
by sterol C4R-methyl oxidase (4-SMO), (ii) oxidative decarbox-
ylationbysterolC4R-decarboxylase(4-SDC)[alsoknownas3β-
hydroxysteroid-dehydrogenase/C4-deacarboxylase, 3βHSD/
D)] complexed with NAD
+ followed by tautomerism, and then
(iii) stereospeciﬁc reduction by a NAD(P)H-dependent sterone
reductase of the 4-monomethyl-3-ketone to the 4-monomethyl-
3β-alcohol catalyzed by sterol 3-reductase (3-SR).
10,164,165 The
second demethylation in which the latter C4R-sterol intermedi-
ate is converted into a 4-desmethyl sterol is mechanistically
identical and is catalyzed by the same membrane-bound cyto-
chrome b5 pathway that participates in the electron carrier from
NADPH to the demethylation complex.
10,166,167
As t e r o lC 4 R-methyloxidase gene has been identiﬁed in
fungi, animals, and plants, and the deduced human protein
contains 293 amino acids and at least four transmembrane
loops.
72,167 169 These proteins share a set of conserved four
histidine clusters typically associated with metal binding. Based
on tracer work and limited speciﬁcity studies, it is generally
accepted that 14-desmethyl lanosterol or 24(28)-methylene-
24,25-dihydrolanosterol(trivialname,eburicol)arerecognized
initially by 4-SMO in animals and fungi, whereas the ﬁrst
substrate bound productively by the plant 4-SMO is 24(28)-
methylene-24,25-dihydrocycloartanol. Three genes encoding
sterol C4 demethylation components in higher plants have
been characterized, and the corresponding gene products
exhibit distinct substrate speciﬁcities: SMO1p has an apparent
substrate speciﬁcity for 4,4-dimethyl-9β-cyclopropyl sterols
and SMO2p shows speciﬁcity for 4R-methyl-Δ
7-sterols. The
3βHSD/D enzyme system, used to carry out the second phase
of C4-demethylation, recognizes either products of SMO1p or
SMO2p catalysis. Homology modeling and site-directed muta-
genesisofthe3βHSD/DfromA.thalianaindicatethatSer
133is
in close proximity to the C4 domain of the bound sterol. The
proposed reaction mechanism for this catalyst involves the
Tyr
159,L y s
163,a n dA r g
326 residues that contribute to the
decarboxylationprocessofC4R-methyl3-ketosterolformation
from a C4β-methyl C4R-carboxy intermediate.
170
5.4. Removal of Nuclear Methyl Group at C14
Sterol C32 removal from C14 is catalyzed by the oxidative
action of sterol 14R-methyl demethylase (14-SDM), a member
of the cytochome P450 superfamily (P450-DM, CYP51,
Erg11p) and a drug target for many diseases caused by fungi
and protozoa.
171,172 There is also evidence in support of the
P450-obtusifoliol-14R-demethylasetobeaherbicidaltarget.
173
Lanosterol 14-demethylase (also CYP51) is a class II enzyme
requiring the FAD FMN-containing NADPH cyctochrome
P450 reductase as redox partner.
174 This remarkable sterol
metabolizing enzyme, in contrast to the sterol C4-demethylase
complex, engenders three distinct oxidation activities and a
fourth activity to promote the diﬃcult removal of the elements
offormicacid.Asof2007,theCYP51familyhasbeenshownto
distribute in 82 organisms from all biological kingdoms. Hu-
mans contain only one CYP51 gene, whereas in some plants
and fungi, multiple CYP51 genes are detected.
172 The human
CYP51 encodes for a protein of 503 amino acids that possesses
a molecular weight of 56806 Da. These catalysts have been
identiﬁed in several prokaryotes, not necessarily with an intact
cholesterol pathway, suggesting that it represents an ancient
metabolicactivity.
175Theaverageaminoacidsequenceidentity
in the CYP51 family is about 30% across biological Kingdoms
with evolutionarily close species, such as mammals, showing
95% identity.
The Erg11p catalyzes the removal of the 14R-methyl group
from the sterol ring via three NADPH O2-dependent steps
organized by a single cytochrome P450. The substrate speciﬁcity
for sterol diﬀers markedly among CYP51 enzymes: the optimal
substrate for enzymes of yeast and animals is lanosterol; for
ﬁlamentous fungi, it is 24(28)-methylene-24,25-dihydrolanoster-
ol; for higher plants, it is 31-nor 24(28)-methylene lanosterol
(obtusifoliol); and for protozoa, it is 31-norlanosterol.
172 These
ﬁndings indicate that depending on the source of enzyme, the
proximal end bearing the polar group of the sterol is critical in
substrate recognition, and the C4β (axial)-methyl group is a
disfavored structural feature in Δ
8-sterol binding to the plant and
protozoan CYP51.
172,176 The importance of the nuclear double
bond position in the C14-demethylation reaction has been
examined in cell-free fungal and bacterial preparations. The
naturallyoccurringΔ
8(9)-andΔ
7(8)-bondsarerecognizedequally
well by CYP51s. However, neither 9β,19-cyclopropyl sterols, or
6-lanostene-3β-32-diol or lanost-3β-32-diol are bound produc-
tively by these enzymes, suggesting that the 8-double bond of
sterols play an important role in the enzyme substrate
interactions.
177,178 The Erg11p from Candida albicans has been
puriﬁed, and the turnover number of the heterologously ex-
pressed protein is 2.5 nmol of Erg11p/mg of protein. Similar
slow turnover numbers have been reported for other cloned and
wild-type puriﬁed 14-SDMs.
179,180
The mechanism of sterol C14-demethylation utilizes cyto-
chrome P450, oxygen, and reducing equivalents to perform
regioselective and regiospeciﬁc oxygen insertion into the mole-
cule followed by methyl removal and double bond formation.
Formation of the 14R-carboxyaldehyde from a 14R-methyl Δ
8-
sterol is followed by an acyl carbon bond cleavage reaction that
involves release of formic acidaccompanied bythe stereospeciﬁc
loss of the 15R-hydrogen atom (H2S originated in MVA) with
creation of the Δ
14(15)-bond.
5 Thus, in proceeding from lanos-
terol where the 15R-hydrogen at C15 is lost to the Δ
8,14-sterol,
the 15β hydrogen is retained and epimerized. The reaction
sequencecanbeinterruptedbyinhibitorsthataresubstrate-based
sterol analogs that contain a functional group at C32 (usually
nitrogen)ornonsteroidal compoundscommonlyknownasazole
drugs, such as ﬂuconazole (a triazole), and other promising
scaﬀolds of nonazole structures typiﬁed by VNI.
181,182 The N-4
(or N-3 of imidazole) of the azole can bind to the heme of the
enzymeasasixthligandwiththeN-1substituentgroupbindingto
the apoprotein.
183 Indeed, the X-ray structures of 14-SDM
crystallized from human and human parasite Trypanosma brucei
showtightbindingofthesedrugsintheactivesitebycoordination
to the heme iron.
184,185 The crystallographic work also shows the
subunit organization of these enzymes to be monomers. The
mode of binding of sterol substrate and azole antifungal agent
with fungal(Cryptococusneoformans) orbacterial(Mycobacterium
tuberculosis) CYP51 was identiﬁed by ﬂexible molecular docking
and through site-direct mutagenesis experiments.
181,186,187 Im-
portant residues that may form contacts with sterol C3-hydroxyl
grouparethecarbonyloxygenofMet
433orthehydroxylgroupsof
Ser
388 or Thr
315. Other critical residues of phylogenetic signiﬁ-
cance have been identiﬁed by substitution of animal/fungi-like
Ile
105 in the B0 helix with phenylalanine. The Ile
105Phe mutant6443 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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proteindramaticallyalterssubstratepreferenceofT.cruziCYP51,
converting it into a more plant-like enzyme.
181
The reaction pathway for the coupled removal of the C32-
group and C15R-hydrogen atom has been a matter of
controversy.
1,2,5,188 190 Enigmatic is whether an 8(14)-sterol is
an obligatory intermediate in the 14-demethylation process and
the nature of the C C bond cleavage reaction that results in the
formation of the 8,14-diene system. For various reasons, the
8(14)-pathway has been deemed either physiologically not
signiﬁcant or a primitive pathway that has been supplanted by
the Δ
8,14-diene pathway in advanced organisms.
2,191 The recent
demonstration of the Saccharomyces cerevisiae GL7 sterol auxo-
troph to convert cycloartenol to 24-methylene 30,31-dinor
cycloartenol (24-methylene pollinastanol) and to the 24(28)-
methylene cycloart-8(14)-dienol product via a presumptive
Δ
8(14)-cyclopropyl sterol intermediate suggests that the Δ
8(9)-
bond in the starting substrate is not obligatory for sterol 32-
demethylation in the yeast system.
192 For the elimination of the
32-aldehyde group, three possible cleavage routes, two of which
proceed through a peroxyhemiacetal intermediate by an ionic or
radicalprocess,havebeenconsidered:(i)Theﬁrstinvolves15R-
hydroxylation followed by nucleophile-facilitated elimination,
which has been discounted by Fisher et al., who have shown
that synthetic 3β,15R-dihydroxylanost-8-en-32-al is not meta-
bolized to 4,4-dimethyl cholesta-8,14-dien-3β,ol under condi-
tions that promote demethylation of lanost-8-en-3,32-diol and
3β-hydroxylanost-8-en-al.
193 (ii) The second involves a reaction
analogous to a Baeyer Villiger oxidation at C14 to produce a
formate ester, which then, through a syn-elimination reaction,
yields the ﬁnal Δ
8,14-sterol.
194,195 This pathway has been dis-
missedbasedon circumstantialevidence using structure activity
and modeling data of related CYP50 enzymes (e.g., sterol
aromatase)thatlendsupporttoadirectdecompositionβ-scission
mechanism.
196,197The preponderance of evidence supports
the sterol C14-oxidation decarbonylation path a, shown in
Figure19,inwhichanintermediatealkoxyradical6convertsto
Δ
8,14-diene product 8.
5.5. Shift of Δ
8 to Δ
5-Position
The formation of the ﬁnal sterol in the pathway is usually
t a k e nt ob eg e n e r a t i o no ft h eΔ
5-bond. The typical pathway
following the formation of the Δ
8,14-sterol by C32 elimination
proceedsasΔ
8,14fΔ
8fΔ
7fΔ
5,7fΔ
5.However,thewell-
described presence of sterols with an unconjugated Δ
5,8(9)-
diene system in fungi and algae and in humans with certain
genetic disorders suggests an alternative route of Δ
8,14 f
Δ
8 f Δ
5,8 f Δ
5,7 f Δ
5,
2,12,72 but not one of Δ
8,14 (with or
withoutthe14RCH3group)fΔ
8(14)fΔ
7fΔ
5,7fΔ
5.The
enzymatic reactions will be discussed in order of their appear-
ance in the sterol biosynthesis pathway starting with the sterol
Δ
14(15)-reductase(14-SR).Thereductionofthe14(15)-double
bond is catalyzed by a microsomal 14-SR with NADPH as
coenzyme in accordance with the outline described for sterol
C24-reduction.
190 The mechanism is triggered by an electro-
philic attack by a proton derived from an active site residue of
the 14-SR on the sterol substrate that results in the C14
intermediate cation shown in Figure 20. The suggested forma-
tionofahigh-energyintermediatewasconﬁrmedbyincubation
with15-azasterols,oneofwhichisanaturalproduct,15-aza-24-
methylene-D-homocholesta-8,14-dien-3β-ol.
198,199 The proton
Figure 21. Enzymatic processing of sterol 8(9)-bond to the 5-position
in rings A and B of the sterol nucleus. The sequence considered is based
on the catalytic competence of the sterol C8-to-C7 isomerase (8-SI),
sterol-5-desaturase (5-SD), and sterol C7-reductase (7-SR) enzymes
tested from animal, plant, and fungi. The stereospeciﬁcities of the
hydrogen losses and additions in the reactions shown have been
elucidated in rat liver and a few other organisms with regard to both
the hydrogen of the sterol substrate and the NADPH coenzyme. Some
variations not shown in the mechanism may exist. See text.
Figure 19. Possible pathways for oxidative removal of the 14R-methyl
group in sterol biosynthesis (R = sterol side chain; Hw
+ is proton from
water) according to Akhtar, Galylor, and cowokers.
193 197 The reaction
is carried out by 14R-sterol demethylase (14-SDM, CYP51) and
proceeds by oxidation of the 14R-methyl group to alcohol 2 and thence
to the C32-aldehyde 4. During cholesterol biosynthesis in rat liver the
lossofC32asformaldehydeisaccompaniedbylossofthe15R-hydrogen
to generate a Δ
8,14-sterol 8. Akhtar et al.
190 proposed two possible
concepts for the elimination of the 32-aldehyde shown in paths a and b,
with path b considered to act under physiological conditions.
Figure 20. Chemical steps in the reaction of sterol 14(15)-reductase
(14-SR) in complex with NADPH to form a Δ
8-sterol. Reduction of the
Δ
14-bond introduces the hydride from NADPH into the 14R-position
and a proton from water (Hw
+) into the 15β-position of 3. This results
inaninversionofthe15β-Hderivedfromtheoriginal14R-methylsterol
precursor (Figure 19) into the 15R-position of the product Δ
8-sterol.6444 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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is added to C15 at the β-position, and the hydride ion from the
coenzyme becomes the 14R-hydrogen. The only reported
puriﬁcation of the enzyme comes from the work of Paik and
Gaylor who found it possessed a turnover number of
40 nmol/(min3mg) for 4,4-dimethyl cholesta-7,14-dienol-3β-
olandwasstronglyinhibitedbyAY-9944.
200Cloningofthe14-
SR gene has been accomplished in yeast and other
systems.
201,202 Analysis of the ERG24 gene indicated a 1316-
bp open reading frame encoding a 438 amino acid protein of a
predicted molecular mass of 50612; similar values have been
reported for other cloned 14-SR proteins.
201,202 In addition to
its role in sterol catalysis, the 14-SR appears to function as a
human lamin B receptor.
203
Isomerization of sterol Δ
8 bond to the Δ
7 position carried
out by sterol 8-to-7 isomerase (8-SI) is triggered by an
R-protonation of the Δ
8 d o u b l eb o n df r o ma na c t i v es i t eg e n e r a l
acid residue, giving a C8 carbocation that is quenched by the
elimination of an appropriate hydrogen atom at C7 by a general
base residue (Figure 21). Studies of MVA labeled with tritium at
C2, C4, and C5 show that loss of 7β-H occurs in animals and
plants (H2R) whereas in fungi the enzyme proceeds with
elimination of the 7R-hydrogen (H2S).
23,204,205 Consistent with
the involvement of a high-energy intermediate in the conversion
of Δ
8 to Δ
7 sterol, various nitrogen-containing drugs that target
breast cancer (tamoxifen) or ischemia (emopamil) or act as
antifungals (tridemorph) inhibit the sterol isomerization reac-
tion in vitro exhibiting dissociation constants in the low nano-
molar range.
206 208 By examining a cationic azadecalin and the
corresponding neutral amide analog of the intermediate formed
in the 8-SI reaction, Rahier and co-workers demonstrated that
the two inhibitors yielded IC50 values of 0.5 μM and more than
100μM,respectively,whichconﬁrmedthatthelattersetofdrugs
functionwithachargedammoniumgroup.
209The8-SIgenerates
a single product, although a small percent of reversibility of the
Δ
8 Δ
7 cholesterol isomerase reaction in cholesterol biosynth-
esis has been demonstrated; at equilibrium, the Δ
7-isomer is
predominant (19/1).
210 Kinetic analyses of the cloned human
enzyme revealed that the free energy (ΔG0) of the forward
isomerization reaction was calculated to be  6.5 kJ/mol.
208 In
contrast, bimimetic studies of sterol Δ
8-isomeration reactions
that show acid-promoted isomerization of the nuclear double
bond in zymosterol yields a combination of Δ
7 and Δ
8(14)-
products. The puriﬁed enzyme from rat and human failed to
convert a 8(14)-sterol to Δ
7-o rΔ
8-sterol.
208,210 Treatment of
Chlorella sorokinia with tritemporph results in the accumulation
of ergost-8(14)-enol and 9,19-cyclopropyl sterols and loss of
cellular ergosterol.
211 In structure metabolism studies using
cultures of sterol auxotrophic yeast GL7, under conditions that
exogenous Δ
8(9)-sterols convert to Δ
5,7-sterols, 8(14)-sterol was
not further transformed in the ring system.
192 These results are
consistent with the proposal that Δ
8(14)-sterols are neither
formed nor metabolized by the same microsomal enzymes that
catalyze transformation of lanosterol to cholesterol.
210
Detailed studies of the substrate speciﬁcity of the human
8-SI indicatedthat thepresenceof C4 andC14 methyl groups,
typical of lanosterol, were harmful to activity; the optimal
substrate is one that possesses a 3β-hydroxyl group, a Δ
8(9)-
double bond, and an intact C8-side chain with a remote
24(25)-double bond.
208 However, humans, fungi, and plant
8-SI diﬀer in their substrate speciﬁcity for cholesta-8,24(25)-
enol,cholesta-8,24(28)-enol(fecosterol),andstigmast-8-enol,
respectively.
207 212 T h e8 - S Ie n z y m eh a sb e e np u r i ﬁed from
rat and human. Properties of cloned human 8-SI are Km of 50
μM, turnover of kcat = 0.423 s
 1, apparent molecular mass of
26.7 kDa, and tetrameric subunit organization. The 8-SI has
beenclonedfromseveralsources,theﬁrstonefromyeastgiven
the ERG2 designation. The predicted molecular weight for
animal, plant, and fungal proteins vary by only 2 kDa, whereas
homology in their primary sequences is low, less than 85%
identity and 50% similarity across kingdoms with plant and
animal sharing a closer relationship in sequence identity to
each other than either group to fungi. Mutagenesis experi-
ments of the human and plant (Zea mays) 8-SI have revealed
that conserved acidic and aromatic residues are involved in
catalysis. Moebius et al. reported that several amino acids at
His
77,G l u
81,T h r
126,A s n
194,a n dT r p
197 of human 8-SI are
required for the isomerization reaction.
206 Rahier et al, study-
ing the Zea mays 8-SI, came to similar conclusions for
equivalently spaced residues in the plant enzyme and estab-
lished further that trytophan residues at positions 66 and 193
play crucial roles, perhaps in cation π interactions during
catalysis,andthatThr
124maybeinvolvedinhydrogenbonding
interactions with the sterol C3-hydroxyl group. It would
appear that a core of critical residues exist in the plant and
animal enzyme that are similarly important to binding and
catalysis,whereastheyareeithernotessentialornotconserved
intheyeast8-SI.Forthisreason,thehighsequencerelatedness
of human and plant 8-SI compared with their catalytic compe-
tence may explain their divergence with the yeast 8-SI that
recognizes diﬀerent substrates and stereochemistry of their
mechanisms.
209
Insertion of the Δ
5-bond into a Δ
7-sterol substrate has been
shown to involve molecular oxygen and cytochrome b5 as the
carrier of electrons from NADPH via NADH-cytochrome b5
reductase and to proceed stereospeciﬁcally in the removal of the
5R (4-ProR in MVA) and 6R hydrogen (5-ProS in MVA) atoms
from the Δ
7-sterol during sterol biosynthesis in animals,
plants, and fungi (Figure 17).
23,213,214 The enzyme sterol 5-de-
saturase (5-SD, E.C. 1.14.21.6) has substrate speciﬁcity that
diﬀers in animals, fungi, and plants for cholest-7-enol, ergosta-7,
22-dienol,andcampest-7-enolorstigmast-7-enol,respectively.
214 217
The gene coding for 5-SD has been identiﬁed in animals, plants,
fungi,andprotozoa(Tetrahymenathermophila);theyeastgeneis
known as ERG3. These proteins diﬀer slightly in size, yet their
amino acid sequences show low relatedness across kingdoms
(<35% identity). On the other hand, they resemble each other
in having three conserved histidine-rich motifs and Thr
114 in the
A. thaliana 5-SD was found to be important in substrate binding
and catalysis.
218,219
Mechanistically, the C5(6)-double bond could be intro-
duced into the Δ
7-sterol by a hydroxylation dehydration
reaction.
2,220 However, recent work by Rahier using 6-aza-B-
homosteroid as an inhibitor of the reaction failed to provide
evidence for a discrete carbocation intermediate in the plant
5-SD reaction, and neither synthetic 5R-cholest-7-en-3β,6R-
diol nor 5R-cholest-7-en-3β,6β-diol were converted to diene
product in the standard microsomal preparation from wild-
type A. thaliana 5-SD.
221 An alternative mechanism was
considered involving a stepwise removal of the C6R-hydrogen
byaniron-boundoxygentogenerateacarbon-centeredradical
at C6, which furnishes the Δ
5-product by a disproportionation
reaction.
221
The 7-dehydrocholesterol reductase (7-SR, EC 1.3.1.21) is
theterminalenzymeinthepathwayofcholesterolbiosynthesis;6445 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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however in phytosterol synthesis additional reaction steps may
come after the formation of the Δ
5-monoene ring, including
Δ
22-desaturation. The 7-reduction of the 7(8)-double bond of
steroidal dienes, investigated in animal and plants, entails the
trans-addition of a proton added from the medium in the
8β-position and the hydride ion from NADPH being added
to the 7R-position.
59 A microsomal preparation from seedlings
of Zea mays catalyzed the NADPH-dependent reduction of the
Δ
7 bond to Δ
5,7-cholestadienol.
222 Evidence for the interme-
diacy of a 7(8)-cation occurring during the reaction was
provided by testing 6-aza-B-homosteroids in the maize micro-
somal assay system, which strongly inhibited the conversion
of a Δ
5,7-sterol to Δ
5-sterol.
223 Ad e ﬁciency of this enzyme
activity due to genetic mutation in humans has been shown to
cause Smith Lemli Opitz syndrome (SLOS).
72,224 The gene
encoding Δ
7-reductase has been cloned and characterized
from the plant Arabidopsis thaliana and fungus Mortierella
alpina.
225,226 The predicted molecular weight of the M. alpina
7-SR is 53965, similar to other 7-SRs. Functional analysis in a
yeastexpressionsystemrevealedthattherecombinant7-SRhas
broad substrate speciﬁcity for steroidal Δ
5,7-dienes. The fungal
7-SR exhibits 39 51% homology with other 7-SR proteins
at the amino acid level and shows two typical sterol family
signatures.
5.6. 9β,19-Cyclopropane Ring Opening
A key enzyme in the biosynthesis of phytosterols, absent
from organisms of a nonphotosynthetic lineage, is the sterol
9β,19-cyclopropane mutase (S-CM), which is often referred to
as the cycloeucalenol obtusifoliol isomerase (COI, EC
5.5.1.9). This membrane-bound microsomal enzyme is respon-
s i b l ef o rt h ec l e a v a g eo ft h e9 β,19-cyclopropane ring of
cycloeucalenol yielding the Δ
8-sterol obtusifoliol.
227 Although
to date the enzyme has not been puriﬁed, structure activity
tests of the microsomal enzymes from bramble (Rubus
fruticosis)a n dc o r n( Zea mays)h a v ep r o v i d e dm u c hi n f o r m a -
tion regarding sterol speciﬁcity; the crucial domains of the
sterol substrate for catalysis are the A- and B-rings.
227 229 The
cycloeucalenol structure, which appears after formation of
24-alkyl sterols in phytosterol biosynthesis, lacks the C4β-
methyl group attached to cycloartenol or 24(28)-methylene
cycloartanol. It would appear that the conﬁguration of the
methyl group at C4 controls the reaction process since 4β-
methyl-cycloeucalenol was not transformed by a cell-free pre-
paration containing COI, and this selectivity may explain the
absence of lanosterol and eburicol in plants generally.
228
Mechanistic studies have shown the reaction proceeds
through an acid-catalyzed mechanism, that is, protonation of
theC9β C19bondbyanacidicsubsiteoftheactivesitesituated
over the C-ring of the substrate followed by a cis region-speciﬁc
elimination of the 8β-H aﬀording the Δ
8-double bond
(Figure 22).
229 In D2O, the COI adds a deuterium to C19 and
abstracts hydrogen from C8, consistent the proposed regiospe-
ciﬁcity of the reaction and involvement of a carbonium ion
generatedatC9followingprotonattackonthenucleophilic9,19-
cyclopropane ring system.
230,231 N-substituted azadecalins, de-
signed as high-energy intermediate analogs of the COI catalyzed
reaction, have been shown to be potent inhibitors of this
reaction.
232 The nonenzymatic acid-catalyzed isomerization of
cycloartenol can proceed to a myriad of rearranged tetracyclic
productsviaeliminationsatC8,C11,andothersites,testifyingto
the conformational control imposed on the isomerization reac-
tion by the isomerase.
233 The COI gene from Arabidopsis
thaliana has been cloned and shown to encode a 36 kDa
protein.
234 Notably, the COI cDNA compared with other plant
sequences revealed that it was present in photosynthetic organ-
isms. However, in no organism from prokaryotes or eukaryotes
of a nonphotosynthetic lineage was signiﬁcant identity to the
plant gene evident.
5.7. C22 Desaturation
The introduction of the C22(23)-double bond occurs at the
antepenultimate step in the ergosterol biosynthetic pathway and
probably the last step of the plant sterol pathway.
2 It, like the
CYP51, is sensitive to inhibition by azole drugs and, like the 24-
SMT, has no counterpart in humans. This reaction has been
showntoinvolvemolecularoxygenandNADPHandisinhibited
by CO and metyrapone, consistent with a cytochrome-P450-
dependentspecies.
235ThesubstratespeciﬁcityofthesterolC22-
desaturase (22-SD) has been studied using cell-free preparations
of Saccharomyces cerevisiae, the sterol yeast mutant GL7 auxo-
trophic for sterol and microsomal preparations of cloned Arabi-
dopsis thaliana and Physcomitrella patens.
236 239 Ergosta-
5,7,24(28)-trienol is considered to be the natural substrate for
the yeast 22-SD and is converted to ergosta-5,7,22,24(28)-
tetraenol in vitro. Sterol structure activity tests using yeast 22-
DESaremostdetailedandshowthatthesizeanddirectionofthe
substituent at C24 aﬀects the percentage of Δ
22-bond formation
rankedasfollowsbasedonGL7studies:24β-C2H5(65%)<24β-
CH3 (50%) < 24R-C2H5 (10%) = 24R-CH3 (5%) = 24H (7%).
24-Methyldesmosterol, thesubstrateforthe24-SR inphytoster-
ol synthesis, was converted to the Δ
22-derivative in 15% yield,
showing that the neighboring double bond at C24 is not a
determent for activity.
237 In contrast, the higher plant 22-SD
recognizes the 24R-ethyl and 24β-methyl group equally well
andthe24R-methylsterolisnotasuitablesubstrate,whereasin
Figure 22. Cleavage of the 9β,19-cyclopropane ring system to form a Δ
8-sterol by sterol 9β,19-cyclopropane mutase (19-SCM) according to Rahier
andco-workers.
229Inorderforthereactiontoproceedina1,2-transmanner,ithasbeenpostulatedthatanegativelychargedgroup(X
 )associatedwith
the cycloeucalenol 1 to obtusifoliol 3 isomerase (COI; 19-SCM) may participate as shown.
12,67 The preferred substrate recognized by COI is a 4R-
methyl 24(28)-methylene sterol, such as cycloeucalenol. The loss of a proton from C11 instead of 8β-H would produce a Δ
9(11)-14R-methyl ring
system, and this may also be a route to this type of sterol in plants and marine organisms.
126446 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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the less-advanced 22-SD from moss (P. patens), 24R-ethyl
sterol was a preferred substrate, but neither 24R-n o r2 4 β-
methylsterolswereacceptablesubstratesfortheC22-desatura-
tion reaction.
238,239 In studies of the protozoan Tetrahymena
pyriformis, additional details regarding the substrate speciﬁcity
for 22-SD were established, and rules of substrate recognition
that govern the introduction of the Δ
22-bond were described.
240
The protozoan 22-SD is diﬀerent from the plant and fungal
22-SDinthatcholesterolistheoptimalsubstratefortheT.pyriformis
enzyme, and campesterol, compared with cholesterol, meta-
bolism is about 50% as eﬀective in conversion to campesta-5,
22-dienol.
The 22-SD has been puriﬁed from Saccharomyces cerevisiae
(CYP51A1)andfoundtopossessanapparentmolecularweight
of58000.TheMichaelisconstantforcloned22-SDfromplants
(CYP107A) was for sitosterol, Km of 1.0 μMa n dVmax of
0.0027 nmol/(nmol P4503min). The kinetic mechanism of
clonedCYP61fromyeasthasbeeninvestigatedbyKellyandco-
workers.
241Catalyticcompetencefortheconversionofergosta-
7,22-dienol to ergosta-5,7,22E-trienol yielded Km =2 5μMa n d
Vmax = 3.1 nmol/(ergosterol formed3min3nmol CYP61). Ki-
netic studies of sterol and NADPH as cosubstrates revealed a
random bi bi mechanism with NADPH donating electrons
directly to NADPH cytochrome P450 oxidoreductase to
produce a reduced intermediary form of the enzyme. The 22-
SD has been cloned from fungi and plants, and the molecular
mass for the A. thaliana mature protein was reported to be
56344 D. The fungal gene is ERG5.
242 These sterol desaturase
enzymesarecharacterizedbygeneralfeaturescommontomost
cytochrome P450-enzymes, have identity across plants and
fungi (>43% identity) and possess a unique stretch, FLFASQ-
DASS, which contains a highly conserved alanine residue
considered to be a contact amino acid in the substrate binding
recognition site.
238,239
The mechanism of the 22-SD has been studied using MVA
labeled with tritium at C2 and C5 and with synthetic substrates
incubated with cell-free preparations of 22-SD.
240,243,244 These
studies revealed that stereoselectivity of removal of hydrogen
f r o mC 2 2a n dC 2 3v a r i e sb e t w e e nf u n g ia n dp l a n t sa n d
protozoa (Figure 23); in fungi two hydrogen atoms are re-
movedfromtheR-face,whereasinplantsandprotozoathetwo
hydrogen atoms are removed from the β-face. In addition, a
hydroxylation dehydration mechanism for the cis-removal of
hydrogen atoms, considered based on metabolite proﬁling,
249
was discounted by Giner and Djerassi who incubated 23R-a n d
23S-hydroergostenols with the yeast 22-SD and found no
evidence of metabolism.
236 The diﬀerent sterospeciﬁcities
and substrate preferences in the 22-SD catalyzed reaction
among fungi and plants and protozoa appear inﬂuenced by
speciﬁc amino acids whose positions and orientation are
responsible for interacting with distinct side chain variants that
determine thelevel of substratediscrimination that occurs with
each enzyme.
6. CONCLUDING REMARKS
We have seen that the outline for similarity and diﬀerences in
sterol biosynthesis across kingdoms is now available; these
originate in the cloning and characterization of enzymes that
form lanosterol and cycloartenol, elucidation of the pathways to
cholesterol and 24-alkylation leading to ergosterol and sitosterol
and the emergence of cloned enzymes that can be overexpressed
aﬀording an exacting analysis of native and mutant protein
properties. Yet, the mechanistic details involved in the reaction
course of many enzymes that catalyze sterols still need to be
worked out. In all the years of pharmaceutical research, sterol
biosynthesis has been a major source for new drug discoveries.
These studies have contributed to our basic knowledge concern-
ing regression of cholesterol biosynthesis in general. With the
increase in fungal resistance and the opportunity to develop
novelmeans forcontrollingsterol biosynthesis pathwaysthat are
absent from humans, the development of new and more potent
antifungal and antiparasitic drugs has been one of the impetuses
of recent biomedical research. Thus, the search for phyla-speciﬁc
pathways that contain unconventional reaction sequences to 24-
alkyl sterols are currently being pursued in a number of labora-
tories. In addition, with the recent determination of the X-ray
structure of sterol enzymes and the ﬁnding that azole drugs used
totreatdiseasesofergosterolbiosynthesizingorganismscanbind
diﬀerentially to human and trypanosome 14R-demethylase en-
zymes opens the door for a new era of rational drug design.
184
Understanding and treating genetic modiﬁcations in sterol
biosynthesisthataﬀecthumanhealthandresearching genetically
modiﬁedsterolpathwaysforimprovementofspeciﬁctraitsorthe
additionofnewtraitstoeconomicallyimportantplantsisanother
major worldwide objective.
Finally, a word on sterol evolution. Bloch gave us the ﬁrst
insight into the role of oxygen and sterol features aﬀecting sterol
competency and biosynthesis, while Ourisson and Rohmer
provided a blue print for a rational progression in time for the
biosynthesisofterpenestohopanoidstotruesterols,whichstarts
in prebiotic systems.
245,246 However, the recent demonstration
of horizontal gene transfer complicates our view for connections
tobacterialoriginsinsterolbiosynthesis.
247Thereisacorrelation
between the presence of the nervous system (animals) and the
absence of certain biosynthetic steps, notably the absence of
sterol C24-alkylation.
29 It is clear that convergent evolution in
ergosterol biosynthesis exists since the ergosterol synthesized in
ProtothecawickerhamiioccursbytheMVA-independentpathway
andthecycloartenolrouteutilizingtheΔ
25(25)-alkylationpathto
24β-methyl group synthesis, whereas the ergosterol formed in
fungi occurs by the classic acetate mevalonate pathway and the
lanosterol route utilizing the Δ
24(28)-alkylation path to 24β-
methyl group synthesis. Equally intriguing to consider are the
prospectsthatsterolbiosynthesisandkineticcontrolofitevolved
Figure 23. Two mechanisms for the cis-dehydrogenation reaction
catalyzed by sterol C22-desaturase (22-SD), also known as CYP51A1
for the fungal enzyme and CYP107A for the plant enzyme, that leads to
the introduction of the C22(23)-E-double bond in the sterol side chain;
HRandHSrefertohydrogenatomsoriginallypartoftheMVAmolecule.6447 dx.doi.org/10.1021/cr200021m |Chem. Rev. 2011, 111, 6423–6451
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by a patchwork assembly with the individual members having
undergone a duplication event followed by divergent evolution
to give rise to the unique speciﬁcities. In this regard, we have
recently shown that the SMT2 with a distinct product set and
substrate speciﬁcity likely originates from SMT1 in phytosterol
biosynthesis and that a correlation exists between the activation
barrier (measured as Ea) to sterol C24-methylation and the
product outcome; a higher energy route (and therefore more
primitive) exists to form Δ
25(27)-24β-methyl sterol compared
with the formation of Δ
24(28)-methylene sterols.
248,249
Although many of the membrane-bound enzymes of sterol
biosynthesis continue to be recalcitrant to crystallization and
they occur in low abundance in tissues, with tools of protein
chemistry, mechanistic enzymology, and structural biology, it is
now possible for a renewed sustained attack on the of the
individual steps in the pathway to address questions that remain:
What about the protein structure that governs product diversity
or recognizes one substrate better than another? Are there any
allosteric modulators that can aﬀect activity? What changes
occurred in enzymes of the oxidosqualene lanosterol and
cycloartenol pathways and of 24-alkyl sterol biosynthesis that
fashioned distinct stereospeciﬁty of reactions that are of phylo-
genetic and functional signiﬁcance.
There is still much to learn about sterol biosynthesis and the
enzymes involved in the pathway. A determination of the
structure and function of all the sterol catalysts is now within
our grasp. The forthcoming decades should be an exciting time
for basic bioorganic chemistry and biochemistry regarding sterol
biosynthesis and production.
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